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ABSTRACT
Susceptibility of Apoptotic Cells to Hydrolysis by sPLA2:
Molecular Basis and Mechanisms Defined
Elizabeth Gibbons
Department of Physiology and Developmental Biology, BYU
Doctor of Philosophy
Secretory phospholipase A2 hydrolyzes phospholipids at a lipid-water interface, resulting
in pro-inflammatory products being released from cell membranes. Healthy cells are resistant to
cleavage by this enzyme, but apoptotic cells become susceptible to its activity. Only bilayers
with certain characteristics are able to be hydrolyzed. Most recently, studies in this lab have
emphasized the idea that the biophysical state of the bilayer (in terms of lipid order, spacing, and
fluidity) is relevant in determining the probability of one phospholipid escaping the membrane to
be hydrolyzed. Prior to this study, it had been shown that apoptotic cells undergo biophysical
alterations that weaken inter-lipid interactions early in apoptosis. The purpose of this dissertation
was to examine these changes in more detail, define them more clearly on the molecular level,
and suggest possible mechanisms responsible for their occurrence.
First, the role of increased membrane permeability in susceptibility to the phospholipase
was investigated. S49 cells were treated with ionomycin or apoptotic agents and assayed for
merocyanine 540 staining of the membrane and membrane permeability to a vital dye. Human
group X and snake venom isoforms were active towards all treated cells, but human groups V
and IIa only hydrolyzed cells that were moderately permeable to the vital dye. Different isoforms
must then be sensitive to different membrane properties.
Second, the role of membrane oxidation in cell membrane vulnerability to the
phospholipase (specifically human group IIa) was tested. The temporal onset of lipid
peroxidation was assayed during apoptosis. This correlated with the onset of susceptibility to the
IIa isoform. Direct oxidizers were then used to verify this result in isolation from other apoptotic
membrane changes.
Third, biophysical alterations during thapsigargin-induced apoptosis were examined
using TMA-DPH and Patman. Data from these probes in artificial bilayers undergoing phase
transitions were used to quantify the decrease in interlipid interactions and predict a 50 – 100fold increase in the probability of phospholipid protrusions. Patman equilibration kinetics also
revealed more molecular detail about the biophysical changes related to susceptibility.
Finally, temperature- and ionomyin-induced alterations in membrane properties were
compared. Both increased fluidity, but only ionomycin caused susceptibility. Patman
equilibration kinetic analysis could distinguish responsible membrane properties. Actin
fragmentation during apoptosis or calcium loading is proposed as the mechanism.
Keywords: secretory phospholipase A2, fluorescence spectroscopy, confocal microscopy, flow
cytometry, membrane biophysics, apoptosis, actin, cytoskeleton

ACKNOWLEDGEMENTS
First, I am so grateful to my family and friends for supporting me and cheering me on
throughout my educational career. My parents especially are my biggest fans. I would like to
thank them for believing that I could do anything and always encouraging me to develop my
talents to the greatest degree possible without ever making me feel pressured to do anything. I
loved it when they read my papers and acted impressed, even if they didn’t completely
understand them.
I don’t know if I have the words to express my gratitude to my mentor, John Bell. I am so
glad I took my freshman biology class from him at age 18 and that he took a chance and let me
into his lab even though it was full. Since then, he has taught me how to think, how to write, and
how to teach. I will miss our brainstorming sessions, writing parties, team-teaching, talks about
life, and inside jokes. He and his wife, Rhonda, are like family to me, and I have loved spending
time in their home.
I would like to thank my amazing graduate committee, Allan Judd, Michael Stark, Sandra
Burnett, and Laura Bridgewater, for investing their time into helping me develop as a scientist.
Dr. Judd especially has been so helpful with both my coursework and research and has become a
dear friend. I will miss his advice and teasing.
I am also grateful for the many people that have worked with me in the lab for the past 7
years. I can’t mention them all by name, but they truly were my second family during my time at
BYU. I am grateful for Anne Heiner and Rachel Bailey for mentoring me as an undergraduate.
As a graduate student, so many lab members contributed to my dissertation: Hannabeth
Franchino, Lauryl Campbell, Mike Streeter, Ashley Warcup, Katalyn Pickett, Celestine Yeung,
Kelly Brewer, Lynn Anderson, Stephanie Melchor, Mike Murri, Eric Moss, and Amy Hamaker.

In particular, Jen Nelson has been both a cherished friend and an invaluable collaborator. Our
conversations about science and life will always be some of my fondest memories in the lab.
Finally, I would like to acknowledge the Laboratory for Fluorescence Dynamics at the
University of California, Irvine for allowing us to use their two-photon microscope. I appreciate
the assistance of Dan Reschke, Trevor Washburn, Ross Ahrendes, and Steve Barben with
confocal microscopy and flow cytometry experiments. I would like to thank Connie Provost for
doing so much behind the scenes that helped me finish this dissertation. I am also grateful for the
funding provided by John Bell (NIH Grant GM073997), the PDBio Department, and the BYU
Cancer Research Center.

TABLE OF CONTENTS

CHAPTER 1: REVIEW OF LITERATURE .................................................................................. 1
Secretory Phospholipase A2 ........................................................................................................ 1
Apoptosis .................................................................................................................................... 3
Classic Apoptotic Membrane Changes ....................................................................................... 6
CHAPTER 2: MATERIALS AND METHODS ............................................................................ 8
Reagents ...................................................................................................................................... 8
Cell Culture and Treatment with Agents .................................................................................... 9
Vesicle Prep ................................................................................................................................ 9
Addition of Exogenous PS ........................................................................................................ 10
Fluorescence Spectroscopy ....................................................................................................... 10
Membrane Susceptibility Assays .......................................................................................... 11
Eq. 1 .................................................................................................................................. 11
Merocyanine 540 .................................................................................................................. 12
DPH and TMA-DPH............................................................................................................. 13
Eq. 2 .................................................................................................................................. 13
Eq. 3 .................................................................................................................................. 14
Laurdan and Patman ............................................................................................................. 14
Eq. 4 .................................................................................................................................. 14

v

Eq. 5 .................................................................................................................................. 14
Flow cytometry ......................................................................................................................... 15
FAM-VAD-fmk .................................................................................................................... 15
Merocyanine 540 and Annexin V ......................................................................................... 16
Propidium Iodide .................................................................................................................. 16
C11-BODIPY581/591 ............................................................................................................... 16
Two-Photon Microscopy .......................................................................................................... 17
Confocal Microscopy ................................................................................................................ 17
C11-BODIPY581/591 ............................................................................................................... 17
Phalloidin .............................................................................................................................. 18
CHAPTER 3: RELATIONSHIP BETWEEN MEMBRANE PERMEABILITY AND
SPECIFICITY OF HUMAN SECRETORY PHOSPHOLIPASE A2 ISOFORMS DURING
CELL DEATH .............................................................................................................................. 19
Introduction ............................................................................................................................... 19
Results ....................................................................................................................................... 21
Susceptibility to sPLA2 of moderately-permeable cells ....................................................... 21
Quantification of hydrolysis ................................................................................................. 25
Comparison between hydrolysis and propidium iodide uptake for various inducers of cell
death ...................................................................................................................................... 25
Comparisons among sPLA2 isoforms ................................................................................... 26

vi

Discussion ................................................................................................................................. 28
CHAPTER 4: ROLE OF MEMBRANE OXIDATION IN CONTROLLING THE ACTIVITY
OF HUMAN GROUP IIA SECRETORY PHOSPHOLIPASE A2 TOWARD APOPTOTIC
LYMPHOMA CELLS .................................................................................................................. 38
Introduction ............................................................................................................................... 38
Results ....................................................................................................................................... 39
Discussion ................................................................................................................................. 42
CHAPTER 5: MOLECULAR DETAILS OF MEMBRANE FLUIDITY CHANGES DURING
APOPTOSIS AND RELATIONSHIP TO PHOSPHOLIPASE A2 ACTIVITY.......................... 50
Introduction ............................................................................................................................... 50
Results ....................................................................................................................................... 52
Death ..................................................................................................................................... 52
Susceptibility to sPLA2 ......................................................................................................... 53
Probes of membrane biophysics ........................................................................................... 54
Discussion ................................................................................................................................. 57
Eq. 6 .................................................................................................................................. 62
Eq. 7 .................................................................................................................................. 62
CHAPTER 6: IONOMYCIN CAUSES SUSCEPTIBILITY TO PHOSPHOLIPASE A2 WHILE
TEMPERATURE-INDUCED INCREASES IN MEMBRANE FLUIDITY FAIL: POSSIBLE
INVOLVEMENT OF ACTIN FRAGMENTATION................................................................... 74
Introduction ............................................................................................................................... 74
vii

Results ....................................................................................................................................... 75
Discussion ................................................................................................................................. 80
CHAPTER 7: SUMMARY........................................................................................................... 95
REFERENCES ............................................................................................................................. 98
CURRICULUM VITAE ............................................................................................................. 117

viii

LIST OF TABLES

Table 1: Changes in TMA-DPH anisotropy and Patman GP during main phase transitions of
DMPC, DPPC, or DSPC vesicles. ................................................................................................ 64
Table 2: Change in frequency of lipid protrusions during TG-induced apoptosis. ...................... 65

ix

LIST OF FIGURES

Figure 3-1: Contour plots of propidium iodide fluorescence and forward light scatter. .............. 33
Figure 3-2: Histograms of propidium iodide fluorescence intensity before and after hydrolysis by
sPLA2. ........................................................................................................................................... 34
Figure 3-3: Time course of distribution of cells among populations defined by propidium iodide
fluorescence intensity before and after hydrolysis by sPLA2. ...................................................... 35
Figure 3-4: Comparison of compartment sizes assessed by various methods for cells treated with
TG, DEX and ionomycin. ............................................................................................................. 36
Figure 3-5: Comparison of initial hydrolysis rates catalyzed by snake venom and human sPLA2
isoforms among cells treated with DMSO, TG, DEX, or ionomycin. .......................................... 37
Figure 4-1: Plasma membrane oxidation during TG-induced apoptosis. ..................................... 46
Figure 4-2: Membrane hydrolysis by hGIIa sPLA2 during TG-stimulated apoptosis. ................. 47
Figure 4-3: Confocal microscopy images of membrane oxidation in cells treated with TBHP,
AAPH, or ionomycin. ................................................................................................................... 48
Figure 4-4: Effects of TBHP and AAPH on hydrolysis by sPLA2 and on membrane order. ....... 49
Figure 5-1: Timing of apoptotic events during TG-induced death. .............................................. 66
Figure 5-2: Susceptibility of TG-treated cells to sPLA2. .............................................................. 67
Figure 5-3: Effect of TG treatment on MC540 fluorescence. ....................................................... 68
Figure 5-4: DPH and TMA-DPH anisotropy and localization in TG-treated cells. ..................... 69
Figure 5-5: Effect of TG incubation on Laurdan intensity and GP. ............................................. 70
Figure 5-6: Patman localization and GP after TG treatment. ....................................................... 71

x

Figure 5-7: Effect of TG on Patman equilibration kinetics. ......................................................... 72
Figure 5-8: Effect of TG on membrane properties and Patman distribution. ............................... 73
Figure 6-1: Effect of temperature and ionomycin on TMA-DPH anisotropy. ............................. 86
Figure 6-2: Example time profiles of ADIFAB GP after sPLA2 addition at 32 and 45 °C. ......... 87
Figure 6-3: Annexin V binding at different temperatures assayed by flow cytometry. ............... 88
Figure 6-4: Susceptibility of cells loaded with exogenous PS. ..................................................... 89
Figure 6-5: Patman equilibration analysis at different temperatures. ........................................... 90
Figure 6-6: Effect of ionomycin on Patman equilibration based on computer simulations and
experiments. .................................................................................................................................. 91
Figure 6-7: F-actin of control cells, ionomycin-treated cells, and cells incubated at 45 °C for 10
min visualized by phalloidin staining. .......................................................................................... 92
Figure 6-8: Effect of temperature and ionomycin on F-actin particle circularity. ........................ 93
Figure 6-9: Actin fragmentation during TG-induced apoptosis. .................................................. 94

xi

CHAPTER 1: REVIEW OF LITERATURE

Secretory Phospholipase A2
Secretory phospholipase A2 (sPLA2) is a hydrolytic enzyme which cleaves the sn-2 ester
bond of phospholipids, yielding lysophospholipids and free fatty acids. It is found in the venom
of various species of snake and bee and there are many human isoforms. It is an excellent model
for an enzyme acting at a lipid-water interface (Scott and Sigler, 1994).
This enzyme is relevant to many pathophysiological conditions. Hydrolysis by certain
isoforms of sPLA2 releases arachidonic acid, an important precursor of pro-inflammatory lipid
mediators (Triggiani et al., 2005), so sPLA2 activity is often associated with inflammatory,
autoimmune, and allergic diseases (Bidgood et al., 2000; Cunningham et al., 2006; Hurt-Camejo
et al., 2001; Ivandic et al., 1999; Pinto et al., 2003; Triggiani et al., 2006; Triggiani et al., 2005).
Secretory PLA2 is also known to be overexpressed in some cancers (Belinsky et al., 2007; Dong
et al., 2010; Kupert et al., 2011). Therefore, targeted chemotherapy is being developed to utilize
the ability of this enzyme to hydrolyze drug-encasing liposomes, releasing drug specifically near
the tumor itself (Andresen et al., 2004; Mock et al., 2013).
Studies aimed at elucidating the regulation of sPLA2 activity began in artificial vesicles.
Early on it was observed that the enzyme exhibited low levels of activity toward liposomes
initially but would eventually undergo rapid activation (Bell and Biltonen, 1989). This lag time
has since been studied extensively and is now known to be due to accumulation of hydrolysis
products in the membrane (Bell et al., 1995; Bell et al., 1996; Halperin and Mouritsen, 2005;
Hoyrup et al., 2004). This latency period can vary based on the fluidity of the membrane, the
organization of lipids in the bilayer, and the presence of certain molecules (such as
diacylglycerol or cholesterol) in the membrane (Bell et al., 1996; Liu and Chong, 1999). The
1

accumulation of fatty acids and lysophospholipids influences both the binding of the
phospholipase and the membrane’s susceptibility to hydrolysis (Henshaw et al., 1998). Studies
with red blood cells or erythrocyte ghosts showed that generally the same properties that govern
membrane vulnerability to hydrolytic attack in artificial systems applies to more complex
membranes (Best et al., 2002; Harris et al., 2001; Heiner et al., 2008).
Work with nucleated cells has proven more complex as expected. In regards to apoptosis,
an interesting phenomenon is observed: healthy cells are naturally resistant to attack by sPLA2,
but membranes of dying cells become susceptible to the enzyme (Atsumi et al., 1997; Nielson et
al., 2000). Bilayer properties must be perturbed enough to allow a single phospholipid to
migrate into the enzyme’s active site and become cleaved (Bailey et al., 2007; Wilson et al.,
1999). Many studies have investigated membrane alterations that could account for this increase
in enzyme activity toward apoptotic cells.
The most well-defined change is PS translocation to the outer leaflet of the membrane.
This alteration of the surface of the cell could provide a more appealing substrate to the enzyme.
Studies in artificial bilayers suggest that various sPLA2 isoforms show increased activity toward
vesicles containing anionic lipids (Bezzine et al., 2002; Jain et al., 1989; Yu et al., 2000).
Annexin V has also been shown to inhibit sPLA2 activity in vesicles containing PS by competing
for the anionic phospholipid interface (Buckland and Wilton, 1998). In addition, exposure of PS
would logically create greater interlipid spacing due to charge repulsion of the head groups. This
reduction in lipid-lipid interactions would lower the energy required for a phospholipid to
migrate from the bilayer.
Another alteration investigated by our lab has been described as an ill-defined change in
the biophysical properties of the plasma membrane. This membrane alteration has been
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suggested in studies utilizing fluorescent membrane probes such as merocyanine 540 (MC540),
Laurdan, and diphenylhexatriene (DPH). These modifications appear to correlate temporally
with susceptibility to sPLA2, but they are vaguely defined as increases in lipid spacing and
fluidity, corresponding with a decrease in membrane order. In addition, it is uncertain whether
the probes used report on the plasma membrane alone or all internal membranes as well (Bailey
et al., 2009; Bailey et al., 2007).
The extent of these characteristics and rate at which they appear differs during various
modes of cell death (Bailey et al., 2009; Bailey et al., 2007; Nielson et al., 2000). In addition,
different sPLA2 isoforms respond to these different changes to varying degrees. For example,
reduction in lipid order is sufficient to render membranes vulnerable to snake venom and the
human group X isozymes, and PS exposure increases that activity (Olson et al., 2010). However,
the human group IIa isoform of sPLA2 showed minimal activity even when PS externalization
and increased membrane fluidity were maximized (Olson et al., 2010). This was surprising
because human group IIa showed preference for negatively-charged lipids in experiments with
artificial bilayers (Singer et al., 2002).
No direct mechanistic explanation for this biophysical change has been elucidated to
date. However, because death induced by calcium ionophore, glucocorticoid, and dibutyryl
cyclic AMP all cause this change, it seems probable a common mechanism shared by all three
inducers is responsible (Bailey et al., 2009; Bailey et al., 2007).

Apoptosis
Apoptosis, or programmed cell death, is a highly regulated and complex process in
nucleated cells. This elegant method of cell destruction plays a critical role in embryonic
development, tissue homeostasis, and immune system development and function (Brill et al.,
3

1999; Budtz and Spies, 1989; Eizirik and Mandrup-Poulsen, 2001; Elmore, 2007; Gressner,
2001; Griffith et al., 1995; Lenardo et al., 1999; Metzstein et al., 1998). Research in this field has
increased exponentially in the past thirty years as malfunctions in the regulation of apoptosis
have proven to be relevant to many different diseases (Diamantis et al., 2008). Some disorders
exhibit inappropriate cell survival (e.g. autoimmunity diseases and cancer) whereas others
include unwanted cell death (e.g. neurodegeneration and heart failure) (Eguchi, 2001; Fadeel
and Orrenius, 2005; Hanahan and Weinberg, 2000; Nagata, 2010; Narula et al., 2006; Okouchi et
al., 2007).
In order to understand apoptosis and thus relevant diseases, much effort has been put into
elucidating the complex signaling pathways involved with this biochemical process. In contrast
with necrosis, unnatural cell death due to injury or trauma, apoptosis is a carefully orchestrated
series of biochemical events designed to shut down and eliminate unhealthy cells without
eliciting an immune or inflammatory response. The line between classical programmed cell
death and necrosis has been blurred as different pathways and mechanisms have been
discovered. Different terms such as necroptosis, caspase-independent cell death, autophagy, and
anoikis have been coined to describe such pathways (Cuny et al., 2008; Grossmann, 2002;
Jaattela and Tschopp, 2003; Leist and Jaattela, 2001).
Two main pathways of classical apoptosis have been described: the extrinsic, initiated by
death receptors on the cell surface; and the intrinsic, characterized by the release of cytochrome c
from the mitochondrial membrane (Elmore, 2007). Recent investigations have also suggested an
additional intrinsic pathway by which apoptosis can be initiated. This third pathway originates
with the unfolded protein response and endoplasmic reticulum (ER) stress (Elmore, 2007; Rao et
al., 2002; Rao et al., 2001). Each of these pathways leads to the activation of a family of
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proteolytic enzymes called caspases (Alnemri et al., 1996). These proteases are synthesized as
inactive proenzymes that become functional upon cleavage. Initiator caspases (including
caspase-8 and -9) cleave and activate effector caspases, the most important being caspase-3, thus
creating a cascade of activation (Elmore, 2007; Vaculova and Zhivotovsky, 2008). In the
execution phase, these effector proteases cleave as many as 400 substrates, including cytoskeletal
proteins, to cause the distinct morphological changes characteristic of programmed cell death
(Benz et al., 2008; Janicke et al., 1998). Caspase-8 is usually associated with the extrinsic
pathway while caspase-9 is activated after mitochondrial alterations. These two pathways
converge on caspase-3 activation, beginning the “execution” phase of programmed cell death
(Elmore, 2007; Hengartner, 2000; Vaculova and Zhivotovsky, 2008). Nakagawa et al. reported
that caspase-12 is localized to the ER and specifically mediates ER stress-induced apoptosis in
murine cell species (Nakagawa et al., 2000). Caspase-12 has been shown to activate caspase-9,
converging with the intrinsic pathway independent of cytochrome c release (Morishima et al.,
2002). Human cell lines do not express caspase-12, but similarly, human caspase-4 is located at
the ER and is activated during ER stress-induced apoptosis (Hitomi et al., 2004).
Calpain, a calcium-activated protease originally associated only with necrotic cell death,
has also been reported to be activated during apoptosis (Squier et al., 1994). Like caspases,
calpains cleave many proteins included cytoskeletal components (Wang, 2000). There is even
evidence for crosstalk between the two cysteine protease families: Nakagawa et al. reported that
calpains can activate caspase-12 at the ER (Nakagawa and Yuan, 2000). Receptor-interacting
protein kinases have been identified as the orchestrators of necroptosis when caspases are
inhibited, as caspases cleave these kinases and inactivate them. These kinases act on
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mitochondrial components, increasing generation of reactive oxygen species (Galluzzi et al.,
2009).

Classic Apoptotic Membrane Changes
Although not as commonly studied, the clearance of cell corpses is just as critical as the
signaling pathways that kill them. Apoptotic cells must be engulfed before harmful substances
leak from the cytosol and cause inflammation. Changes in the plasma membrane during the
dying process are critical to tag the cell for phagocytosis (Fadeel et al., 2010; Witasp et al.,
2008).
Plasma membrane blebbing is one of the main morphological features of apoptosis. Late
in apoptosis, the lipid bilayer buds off to form membrane blebs which become apoptotic bodies
(Elmore, 2007). These bodies contain contents of the nucleus and cytosol and are engulfed by
phagocytes cleanly to reduce inflammation (Coleman et al., 2001). Studies have suggested that
blebbing requires a reduction in cytosolic volume, plasma membrane detachment from the
cytoskeleton, actin reorganization, and myosin activation (Coleman et al., 2001; Mitran and
Young, 2011; Nunez et al., 2010). Caspases cleave rho-associated protein kinase (ROCK I)
which promotes coupling of actin-myosin filaments, causing membrane blebbing (Coleman et
al., 2001).
Since it was first reported in 1992, the exposure of phosphatidylserine (PS) on the cell
surface has become recognized as one of the characteristic features that identifies apoptotic cells
(Fadok et al., 1992). Anionic PS is normally sequestered in the inner leaflet of the plasma
membrane in healthy cells. During cell death, this asymmetry is lost as the phospholipids are
scrambled and PS is externalized (Raggers et al., 2000; Verkleij and Post, 2000). This
negatively-charged lipid exposed to the surface of the cell triggers the elimination of the cell by
6

macrophages (Fadeel and Orrenius, 2005; Fadok et al., 1998; Fadok et al., 2000; Fadok et al.,
1992). Multiple proteins have been discovered that are involved in phospholipid translocation
across the membrane. Flippase (aminophospholipid translocase) is ATP-dependent and specific
to the negatively-charged phospholipids PS and phosphatidylethanolamine. Flippase is
responsible for transporting these lipids to the inner leaflet and is inhibited during apoptosis
(Devaux et al., 2008; Seigneuret and Devaux, 1984; Zachowski et al., 1986). Floppase is also an
ATP-dependent protein, but it is outward-directed and primarily nonspecific (Daleke, 2003;
Dekkers et al., 1998; Serra et al., 1996). A third protein, scramblase, is not ATP-dependent and
facilitates bidirectional movement to disrupt membrane asymmetry. It is normally inactive in
healthy cells but is activated by calcium during cell death (Basse et al., 1996; Raggers et al.,
2000; Zhou et al., 1997). Additional mechanisms such as lipid peroxidation could also
contribute to PS exposure (Raggers et al., 2000; Tyurina et al., 2004; Verkleij and Post, 2000).
Some propose that oxidized PS could possibly form hydrophilic transbilayer pores in the
membrane, making the diffusion of phospholipids across leaflets more energetically favorable
(Tyurina et al., 2004).
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CHAPTER 2: MATERIALS AND METHODS

Reagents
Secretory phospholipase A2 isoforms were isolated and prepared as described:
monomeric aspartate-49 sPLA2 from the venom of Agkistrodon piscivorus piscivorus (AppD49)
(Maraganore et al., 1984), hGIIa (Baker et al., 1998; Markova et al., 2005), hGV (Cho et al.,
1999), and hGX (Pan et al., 2002). Snake venom sPLA2 was generally used because of its
availability and sensitivity to biophysical changes in the plasma membrane.
Ionomycin, 1,6-diphenyl-1,3,5-hexatriene (DPH), 1-(4-trimethylammoniumphenyl)-6phenyl-1,3,5-hexatriene (TMA-DPH), acrylodan-labeled fatty acid-binding protein (ADIFAB),
propidium iodide, 6-dodecanoyl-2-dimethylaminonaphthalene (Laurdan), 6-palmitoyl-2-[[2(trimethylammonio)ethyl]-methylamino]naphthalene chloride (Patman), 4,4-difluoro-5-(4phenyl-1,3-butadienyl)-4-bora-3a,4a-diaza-s-indacene-3-undecanoic acid (C11-BODIPY581/591),
MC540, Alexa Fluor® 488 Phalloidin Conjugate, and annexin V Alexa Fluor® 488 conjugate
were all purchased from subsidiaries of Life Technologies (Grand Island, NY). The
carboxyfluorescein-labeled peptide (Val-Ala-Asp) fluoromethylketone caspase inhibitor (FAMVAD-fmk) was acquired from Cell Technology (Mountain View, CA). Thapsigarin (TG),
NecroX-5™, and Z-Val-Ala-Asp(OMe)-Fluoromethylketone (Z-VAD-fmk) were both acquired
from Enzo Life Sciences (Plymouth Meeting, PA). Dexamethasone (DEX) and tert-Butyl
hydroperoxide (TBHP) were purchased from Sigma-Aldrich (St. Louis, MO). 2,2'-azobis-2methyl-propanimidamide, dihydrochloride (AAPH) and 6-hydroxy-2,5,7,8-tetramethylchroman2-carboxylic acid (Trolox) were purchased from Cayman Chemical (Ann Arbor, MI). These
agents were dissolved in N,N-dimethylformamide (DMF), dimethylsulfoxide (DMSO), or
aqueous buffer as appropriate. Formaldehyde (16%, no methanol) was obtained from Thermo
8

Fisher Scientific (Rockford, IL). Lipids were purchased from Avanti Polar Lipids (Birmingham,
AL). All other reagents were obtained from standard suppliers.

Cell Culture and Treatment with Agents
S49 mouse lymphoma cells were grown in suspension in Dulbecco’s Modified Eagle
Medium at 37 °C (10% CO2) as explained (Wilson et al., 1997). Cells were treated in culture
with TG (5 µM), DEX (100 nM), AAPH (3 mM, dissolved in culture medium fresh immediately
prior to each experiment), or equivalent volumes of the associated vehicles (parallel incubation
times, DMSO ≤ 0.1% v/v). When applicable, Z-VAD-fmk (50 µM) was added in culture 30 min
before TG or DMSO. For experiments, cells were collected by centrifugation, washed, and
suspended (0.25–3.5 x 106 cells/ml) in a balanced salt medium (NaCl = 134 mM, KCl = 6.2 mM,
CaCl2 = 1.6 mM, MgCl2 = 1.2 mM, Hepes = 18.0 mM, and glucose = 13.6 mM, pH 7.4, 37 °C).
Treatments with ionomycin (300 nM) or TBHP (0.4 mM) were done in the balanced salt medium
after cell harvesting. All experiments, treatments, and incubations were conducted at 37 °C
unless otherwise specified. Sample viability was assessed by trypan blue exclusion. Unless stated
otherwise, all error representations are SE.

Vesicle Prep
Multilamellar vesicles were made using 1,2-dipalmitoyl-sn-glycero-3-phosphocholine
(DPPC), 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC), or 1,2-distearoyl-sn-glycero-3phosphocholine (DSPC). Samples (0.1 µmole phospholipid dissolved in chloroform) were
dispersed with TMA-DPH (1:200 probe:lipid), dried under a N2 gas stream, and suspended in 2
mL citrate buffer (20 mM sodium citrate/citric acid, 150 mM KCl, pH 7). Suspensions were
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incubated 1 h in a shaking water bath at ≥ 50 °C (or ≥ 60 °C for all samples containing DSPC)
with intermittent vortex mixing at 10-min intervals.
For experiments in which PS was added exogenously to S49 cells, vesicles containing
50% L-α-phosphatidylserine (PS; brain, porcine) and 50% L-α-phosphatidylcholine (PC; egg,
chicken) were used. Lipids were dried under nitrogen and resuspended in PBS (1 mM final). In
order to make unilamellar liposomes, samples were sonicated in a Misonex Sonicator 3000 (20
kHz) at 2 watts for 3 min.

Addition of Exogenous PS
For assays in which PS was added exogenously to the cell membrane, cells were
harvested as described above and resuspended to a volume of 0.5 – 1.5 million cells/mL. Cells
were then incubated with 50% PS, 50% PC liposomes (50 μM final) for 30 min at 37 °C.
Samples were then washed via centrifugation and resuspended in a balanced salt buffer for
experimentation.

Fluorescence Spectroscopy
Time-based fluorescence intensities and emission spectra were collected with a
Fluoromax (Horiba Jobin Yvon, Edison, NJ) photon-counting spectrofluorometer. Anisotropy
measurements were taken with a PC-1 (ISS, Champaign, IL) photon-counting
spectrofluorometer. Continuous gentle stirring with a magnetic stir bar ensured sample
homogeneity, and temperature was maintained by a jacketed sample chamber fed by a circulating
water bath. Bandpass was set at 16 nm for anisotropy measurements and 4 nm for all other
experiments. When necessary, fluorescence emission at multiple wavelengths was acquired by
rapid sluing of monochromator mirrors. Cell samples were treated and prepared as described
10

above and equilibrated in the fluorometer sample chamber for at least 5 min before initiating data
acquisition. Vesicles were equilibrated at each temperature for 10 min before collecting data
unless indicated otherwise.

Membrane Susceptibility Assays
Cell membrane hydrolysis catalyzed by various sPLA2 isozymes (35–70 nM) was
measured by assaying fatty acid release using ADIFAB (65 nM final) as described (Olson et al.,
2010). Most experiments were conducted using the AppD49 isozyme as a standard for
comparison to previous studies and because it mimics many general behaviors of the human
enzymes (Olson et al., 2010). Key results were then repeated with hGIIA, hGV, and hGX.
The amount of fatty acid released was quantified by comparing ADIFAB fluorescence
emission (65 nM final; excitation = 390 nm) at 432 and 505 nm (I432 and I505) and calculating the
generalized polarization (GPADIFAB) as described (Richieri and Kleinfeld, 1995; Wilson et al.,
1997):
Eq. 1

GPADIFAB 

I 505  I 432
I 505  I 432

Cells treated with DMSO, TG, or DEX were incubated for 600 s with the enzyme. The
maximum displacement in ADIFAB GP during this incubation period was calculated to quantify
the amount of hydrolysis by sPLA2. In some instances, this displacement was then divided by the
equivalent value obtained from parallel experiments with cells treated 10 min with 300 nM
ionomycin. Ionomycin renders 100% of S49 cells vulnerable to hydrolysis by AppD49 sPLA2
(Bailey et al., 2007) and was therefore used as a standard to establish the maximum for
normalization. For experiments involving human isoforms of sPLA2, the total amount of
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hydrolysis possible under the various experimental conditions was estimated using AppD49
sPLA2.
The initial hydrolysis rate was quantified for each isozyme by measuring the
displacement in ADIFAB GP during the initial 5 s (AppD49), 20 s (hGX), or 50 s (hGV or
hGIIa) of the hydrolysis time courses and then dividing that value by the length of the
incubation. The specific activity of each enzyme preparation was assayed by likewise assessing
the initial hydrolysis rate using DPPG liposomes (25 µM lipid) as substrate. The maximal
hydrolysis rate was estimated by fitting the data to an arbitrary function (sum of exponentials) by
nonlinear regression and calculating the first derivative of the resulting curve.
Plasma membrane susceptibility to sPLA2 was also indirectly assayed using a vital dye.
Propidium iodide fluorescence was collected over time (excitation = 537 nm, emission = 617
nm) as propidium iodide (37 μM final), sPLA2 (70 nM final), and triton X-100 were added
sequentially. Triton X-100 permeabilizes all cells and provides the maximal fluorescence. The
proportional rise in propidium iodide fluorescence after the addition of both propidium iodide
and sPLA2 was quantified by fitting fluorescence intensity time courses with an arbitrary
function by nonlinear regression. The subpopulation of cells that were alive but susceptible to
sPLA2 was quantified as the fraction of total propidium uptake that occurred after sPLA2
addition. The data were adjusted to account for cells with degraded DNA (invisible in this assay)
using data obtained from flow cytometery (see below). Details of these calculations have been
reported previously (Olson et al., 2010).

Merocyanine 540
Merocyanine 540 (170 nM final) spectra (excitation: 540 nm, emission: 550 to 700 nm)
were collected before probe addition (to assess stray light background), after 5 min equilibration
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with MC540, and after 10 min treatment with 300 nM ionomycin (a calcium ionophore which
quickly initiates a maximal MC540 response (Bailey et al., 2007)). Intensity values from 565 to
615 nm were summed to quantify the overall intensity for each spectrum. The intensity of the
first spectrum was subtracted from the second, and the difference was divided by the intensity of
the third spectrum (also corrected for background) to standardize for cell number. To quantify
shifts in the spectral peak, spectra were fit by nonlinear regression to an arbitrary function (sum
of Gaussian curves). The peak wavelength was then calculated as the point at which the first
derivative of the generated curve was equal to zero. The magnitude of spectral shifts was
calculated by subtracting the peak wavelength of the second spectrum from the third
(ionomycin). The data are expressed as the average change in peak wavelength after ionomycin
addition for the control group minus the change observed for each individual sample. The
intensity of MC540 fluorescence (170 nM final) was assayed at 585 nm (excitation = 540 nm) as
described (Bailey et al., 2009; Bailey et al., 2007).

DPH and TMA-DPH
Measurements of DPH and TMA-DPH (2.5 μM final) fluorescence were collected with
different configurations of excitation (350 nm) and emission (452 nm) polarizers in the vertical
and horizontal positions after 10 min equilibration of cells with the probe. The anisotropy (r) was
then calculated from the fluorescence intensity when both polarizers were vertical (I//) and when
the excitation was vertical and the emission horizontal (I . Correction for differential
transmission and detection at the two polarizer positions was included (G) according to
convention:

Eq. 2

r

I //  GI 
I //  2GI 

13

Anisotropy measurements were also made with DMPC, DPPC, or DSPC multilamellar vesicles
equilibrated with TMA-DPH during vesicle preparation as described above. Samples were
equilibrated first with the probe and then 5 min at each temperature in 1–2 °C increments
spanning the main phase transition for each lipid (DMPC: 15–35 °C; DPPC: 18–50 °C; DSPC:
18–60 °C). The change in anisotropy associated with the phase transition was calculated as the
difference in limiting anisotropy values at the two ends of the transition (rlow and rhigh) obtained
by nonlinear regression using the following:
r  rlow 

Eq. 3

rhigh  rlow
1  e n (Tm T )

where n is the cooperativity of the transition, and Tm is the melting temperature.

Laurdan and Patman
Both Laurdan and Patman (250 nM final) fluorescence intensity measurements were
acquired as a function of time with excitation at 350 nm and emission collected at 435 and 500
nm (I435 and I500). Spectral changes were quantified by calculating the generalized polarization
(GP) as follows (Parasassi et al., 1991):
Eq. 4

GP 

I 435  I 500
I 435  I 500

For Patman equilibration analyses for TG and temperature studies, time courses of probe
intensity were smoothed by nonlinear regression to an arbitrary function (analogous to Eq. 5) and
normalized to the intensity at 435 nm at 400 s to aggregate data from multiple replicate samples.
These pooled data were then fit by nonlinear regression to the following:
Eq. 5

I  A(1  ebt )  C (1  e dt )  F
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where A and C are arbitrary scalars, b and d are rate constants, and F is the intercept intensity.
Intensities at both wavelengths were fit together with b and d constrained as shared parameters.
These fitting parameters were then used to calculate model parameter values (fraction of probe in
each configuration, polarity of each configuration, and rate of probe entering each configuration)
according to Eqs. 11–14 in Franchino’s 2013 study (Franchino et al., 2013). Error was estimated
by using the extreme values of the 95% confidence intervals for each fitting parameter generated
by nonlinear regression. Every permutation of these fitting parameters was inputted into Eqs. 11–
14 (Franchino et al., 2013) to determine the range of possible model parameter values. This
range is illustrated as error bars in the relevant figure.
For Patman equilibration studies with ionomycin, the ionophore was added after probe.
These intensity profiles were fit according to an arbitrary function similar to Eq. 5 with a third
exponential term applied after the time of ionomycin addition. The rate of this third exponential
term was constrained to be shared among the 435 nm and 500 nm curves.

Flow cytometry
All flow cytometry samples were immediately processed (without fixation) in a BD
FACSCanto flow cytometer (BD Biosciences, San Jose, CA) with an argon excitation laser (488
nm). Emission was assessed using a bandpass filter at 515–545 nm (FAM-VAD-fmk, annexin V,
or C11-BODIPY581/591) or 564–606 nm (propidium iodide and MC540).

FAM-VAD-fmk
For caspase assays, FAM-VAD-fmk was added in culture 30 min before cell harvesting
according to instructions provided with the vendor’s kit. Because peaks were not easily
distinguishable for analysis by gating, histograms of FAM-VAD-fmk intensity were fit with a
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sum of Gaussian curves. The area under the curves composing the more positive peak was used
to represent the percent of the population staining positive for caspase activation.

Merocyanine 540 and Annexin V
Merocyanine 540 (250 nM) was added after cells were resuspended in buffer and samples
were processed after a 10 min incubation. Merocyanine 540 data were analyzed in the same way
as for the caspase assay. The annexin V Alexa Fluor® 488 conjugate was used to assay PS
externalization according to manufacturer’s instructions (Life Technologies, Grand Island, NY).
A gate representing positive staining was determined from either samples containing no probe or
from stained control cells as specified in figure legends.

Propidium Iodide
After harvesting, cells were stained with propidium iodide (10 µM) for 10 min. Where
indicated, 70 nM sPLA2 was also included. To quantify the number of cells cdontaining
hypodiploid-staining DNA due to fragmentation, propidium iodide and Triton X-100 were used
in conjunction as described (Riccardi and Nicoletti, 2006). This proportion was determined by
setting a gate below the peak representing G1-phase DNA staining.

C11-BODIPY581/591
When assaying oxidative potential, cells were incubated with C11-BODIPY581/591 (2 µM
final) for at least 1 h in culture prior to treatment with TG or an oxidizer. Fluorescence
histograms of control sample fluorescence were fit to a Gaussian curve. Fluorescence histograms
of treated samples were then fit with two Gaussian curves with one constrained to the mean and
standard deviation of the corresponding control. The area under the second Gaussian curve
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normalized to the total fluorescence was reported as the percent of the population staining
positive for oxidized C11-BODIPY581/591.

Two-Photon Microscopy
Two-photon excitation microscopy was performed at the Laboratory for Fluorescence
Dynamics (Irvine, CA) using an Axiovert 35 inverted microscope (Zeiss, Thornwood, NY). S49
cells were prepared for experiments as described above, treated with Laurdan, Patman, DPH, or
TMA-DPH (250 nM final), and equilibrated for 10 min before data acquisition. Excitation was
usually set at 753 nm, but when experiments involved only Laurdan or Patman, 780 nm was used
because of more efficient excitation. Using software obtained from the Laboratory for
Fluorescence Dynamics, histograms of Laurdan GP were created for both the whole cell and the
middle of each cell (54 ± 5% (SD) of image pixels). The average GP for the perimeter of the cell
was calculated as the difference between the average GP of the whole cell and its middle.

Confocal Microscopy
Images were collected on an Olympus FluoView FV 300 confocal laser scanning
microscope using a 60x oil immersion objective lens.

C11-BODIPY581/591
Cells were stained with C11-BODIPY581/591 (2 µM final) for at least 1 h in culture prior to
treatment with TG or an oxidizer. Two different lasers and emission filter sets were used
concurrently to excite and collect fluorescence from both oxidized (488 nm argon laser, 505–525
nm bandpass emission filter, green color in images) and non-oxidized probes (543 nm heliumneon laser, 560–660 nm bandpass emission filter, red color in images). Experimental temperature
was maintained throughout imaging using a heated stage.
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Phalloidin
For actin studies, cells were simultaneously fixed, permeabilized, and stained with
fluorescent phalloidin (Alexa Fluor© 488) according to the manufacturer’s protocol (Life
Technologies). After being mounted onto slides, cells were stained with a solution containing
165 nM phalloidin, 3.7% formaldehyde, 1% bovine serum albumin, and 0.1 mg/mL lyso-PC (1palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine) for 20 min at 4 °C. Slides were then washed
with buffer before coverslips were mounted. The 488 nm argon excitation laser was used.
ImageJ software was used to quantify the circularity index of all particles in each image
(Schneider et al., 2012). Color images were converted to 8-bit greyscale images and inverted so
particles were dark against a white background. After subtracting background, the images were
converted to 1-bit black and white images before the particles were analyzed. The data are
represented as the percentage of total pixels that appear in particles of highest circularity index
(0.75 – 1).
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CHAPTER 3: RELATIONSHIP BETWEEN MEMBRANE PERMEABILITY AND
SPECIFICITY OF HUMAN SECRETORY PHOSPHOLIPASE A2
ISOFORMS DURING CELL DEATH

Introduction
Early attempts at distinguishing apoptotic and necrotic cells often focused on
permeability of the cells to vital stains such as propidium iodide (reviewed in (Darzynkiewicz et
al., 1997). The original paradigm was that necrotic cells are immediately permeable to the dye
while apoptotic cells display a significant temporal delay before they become stained. It was
soon discovered that the latent permeability to propidium iodide during apoptosis is not an “all or
none” phenomenon. Instead, there is a gradual acceleration of probe uptake that initially
produces faint cellular fluorescence quantifiable only by flow cytometry but eventually
culminating in complete staining of the cells (Vitale et al., 1993; Zamai et al., 1996).
Presumably, this gradual acceleration represents alterations to the structure and dynamics of the
cell membrane that progressively become more pronounced. Although these observations have
been substantiated by several investigators, the focus has been confined to development of assay
methods; determinations of mechanisms and physiological/pathological consequences have
lagged.
Another membrane event that occurs during early apoptosis is an increase in the ability of
secretory phospholipase A2 (sPLA2) to hydrolyze phospholipids and release fatty acids and
lysophospholipids from the outer face of the plasma membrane (Atsumi et al., 1997; Bailey et
al., 2009; Bailey et al., 2007; Nielson et al., 2000; Olson et al., 2010). This interesting
relationship between sPLA2 and apoptosis is an extension of a broader paradigm that healthy
cells resist hydrolysis by the enzyme whereas membranes of damaged or dying cells are
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vulnerable (Atsumi et al., 1997; Bailey et al., 2009; Bailey et al., 2007; Jensen et al., 2005;
Nielson et al., 2000; Olson et al., 2010; Wilson et al., 1999). At least some of this enhanced
vulnerability to hydrolytic attack is observed in apoptotic cells that have not yet become fully
stained by propidium iodide (Bailey et al., 2009; Bailey et al., 2007; Nielson et al., 2000; Olson
et al., 2010). Apparently, the increased susceptibility to hydrolysis also represents alterations to
the structure and dynamics of the cell membrane (Bailey et al., 2009; Bailey et al., 2007; Best et
al., 2002; Bezzine et al., 2002; Harris et al., 2001; Jensen et al., 2005; Singer et al., 2002; Smith
et al., 2001). Biophysical studies of this phenomenon have yielded some clues as to what these
alterations might involve. Possible candidates include increased lipid spacing, decreased lipid
order, and increased exposure of phosphatidylserine on the outer face of the cell membrane
(Bailey et al., 2009; Bailey et al., 2007; Olson et al., 2010). Nevertheless, a complete
understanding of the nature of relevant membrane changes during early apoptosis has not yet
been achieved. These observations raise the question of whether the alterations that permit
hydrolysis by sPLA2 might correspond to those that allow modest permeability to propidium
iodide. Answering that question could clarify mechanisms involved in controlling sPLA2 activity
as well as a possible novel biological significance for subtle changes in membrane permeability
to vital stains during apoptosis.
To address this question, we examined responses to various death stimuli using flow
cytometry to classify populations of cells based on their intensity of staining with fluorescent
probes that detect specific membrane properties. The objective was to identify which populations
were most susceptible to enzymatic attack and determine how those populations related to
permeability to propidium iodide and other physical properties. We included agents that initiated
death through endoplasmic reticulum stress, glucocorticoid receptor stimulation, and calcium
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loading. Although we compared results using each of these stimuli, we focused most of our
attention on endoplasmic reticulum stress caused by the calcium ATPase inhibitor TG (Bian et
al., 1997; Kass and Orrenius, 1999; Nielson et al., 2000; Yoshida et al., 2006). Thapsigargin was
emphasized because it induces apoptosis rapidly in S49 cells thereby augmenting the size of
relevant populations by maintaining high synchrony of cells as they proceed through the death
process. In addition to propidium iodide, MC540 was used as a marker of increases in interlipid
spacing and membrane lipid disorder that have been reported to enable hydrolysis by sPLA2
(Ashman et al., 1995; Bailey et al., 2009; Bailey et al., 2007; Mower et al., 1994; Olson et al.,
2010; Stillwell et al., 1993). Exposure of phosphatidylserine was eliminated as a variable by
including death stimuli and incubation times known to result in optimal exposure of the anionic
phospholipid on the extracellular membrane surface (Ahn et al., 2004; Diaz et al., 1999; Martin
et al., 1995; Mazur et al., 2009; Nielson et al., 2000).

Results

Susceptibility to sPLA2 of moderately-permeable cells
S49 lymphoma cells were treated for 3 h with TG or control vehicle (DMSO), stained
with propidium iodide, and classified based on staining intensity by flow cytometry. Figure 3-1
illustrates contour plots of the flow cytometry results. As shown in Fig. 3-1A, three distinct
populations were identified in control samples based on their level of propidium iodide
fluorescence intensity (ordinate axis). The designation “P” refers to those cells staining positive
for propidium iodide. This population was indistinguishable from cells that had been
permeabilized by the detergent Triton-X 100 (not shown). Therefore, it is assumed to represent
cells with permeable membranes. The negative population (“N”) did not stain with propidium
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iodide since the apparent fluorescence intensity was comparable to the background observed
with cells that had never been exposed to the dye. A third population was labeled “I” for
intermediate. The average staining intensity of this population was about 10 times that of the
negative population but only1/30 that of the positive population. Cells in the negative and
positive populations exhibited stable fluorescent intensities over time. However, for the
intermediate population, the degree of staining increased incrementally over time. The cells
shown in Fig. 3-1A were representative of typical control samples (84.3% negative, 11.3%
intermediate, 4.4% positive).
A likely interpretation of the intermediate population was suggested in a study by Vitale
(Vitale et al., 1993). The researchers proposed that it represents a trait inherent to apoptotic
cells—slightly compromised membranes that have therefore become modestly permeable to
propidium iodide. To examine the applicability of this idea to apoptotic S49 cells, we monitored
the distribution of propidium iodide staining at different times after introduction of the dye to a
TG-treated sample. We assumed that if the intermediate population represented cells with
modest permeability, the population would gradually migrate along the fluorescence intensity
axis of the contour plot while the negative and positive populations would remain stable. As
shown in Panels B–D, the positive population was clearly defined, contained a greater number of
cells than in the control sample (12% compared to 4%), and remained stable in intensity over
time. Initially, cells staining with low intensity were distributed across both the negative and
intermediate regions (Panel B). As time progressed, a population with higher intensity staining
emerged and migrated along the ordinate indicating that the amount of staining per cell was
increasing. By 10 min, the two populations had resolved into the negative and intermediate
regions.
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Figure 3-2 shows histograms of fluorescence intensity from an experiment like that of
Fig. 3-1 for cells incubated without (black curves) or with (red curves) sPLA2. In control samples
(Panel A), 10-min treatment with sPLA2 produced only minor alterations. With TG-treated cells
(Panel B), the effects of hydrolysis by sPLA2 were obvious. The proportion of cells found in the
positive peak tripled. These were accounted for quantitatively by a comparable reduction in the
number occupying the intermediate peak. The proportion of cells found in the negative
population stayed about the same with a small increase in staining intensity, suggesting a minor
perturbation to those cells, perhaps from modest hydrolysis. This result suggested that cells in the
intermediate peak are a prominent target of sPLA2.
Figure 3-3A represents the evolution of the various populations of apoptotic cells over
time after addition of propidium iodide. Consistent with the results in Fig. 3-1, the main change
was a time-dependent migration of cells from the negative region (black lines and symbols) to
the intermediate region (red). A moderate rise in the number of cells staining positive was also
observed (blue). Panels B and C demonstrate the effect of sPLA2 on the distribution of
populations over time. The main effect was conversion of the intermediate population to positive
cells, presumably due to membrane damage during hydrolysis. As expected, very little
hydrolysis was detected in untreated control samples.
As indicated by the relative areas under the black and red curves in Fig. 3-3D, only about
40% of the cells in the intermediate population was hydrolyzed by sPLA2 (i.e. 22–29% of the
total sample). There were at least two reasons that cells remained in the intermediate population
after addition sPLA2. First, a subpopulation of the intermediate group was already fully
permeable to propidium iodide but stained with low intensity because of DNA fragmentation.
The existence of this subpopulation was verified by addition of Triton X-100 (Riccardi and
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Nicoletti, 2006). Obviously, hydrolysis would have had no impact on the intensity of propidium
iodide staining of this subpopulation. We performed parallel control experiments to quantify the
contribution of these hypodiploid cells to the result. We found that about 10% of the sample
contained fragmented DNA under the conditions of Fig. 3-3, which would account for about a
fourth of the intermediate cells that did not change staining intensity after sPLA2 treatment (not
shown).
The second reason why the remaining cells in this population did not appear to be
hydrolyzed is not clear; however, one clue may come from close examination of the histograms
shown in Fig. 3-2. The average staining intensity for the intermediate population was reduced by
an average of 0.15 log units after hydrolysis by sPLA2. This effect is shown in Fig. 3-3D
comparing the residual intermediate subpopulation (red) with that apparently removed by
hydrolysis (blue). This difference between the vulnerable and resistant subpopulations in the
intermediate cohort was reproducible; the lack of overlap between the 95% confidence intervals
for the respective histogram means shown in Fig. 3-3D was true for all of the replicate samples
in Fig. 3-3. This result indicates that the vulnerable subpopulation has a slightly greater
permeability to propidium iodide (about 41% greater) compared to those that remain resistant. If
the intermediate population represents cells with membranes perturbed in a way that makes them
susceptible to hydrolysis, then the data presented here would suggest that the enzyme is quite
sensitive to the magnitude of that perturbation, and only those cells with sufficient permeability
above a narrow threshold are attacked. This result is reasonable for sPLA2 given the extreme
sensitivity of the enzyme to subtle changes in artificial membranes (Bell and Biltonen, 1989;
Honger et al., 1996; Lichtenberg et al., 1986).
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Quantification of hydrolysis
Experiments parallel to those in Fig. 3-3 were conducted spectroscopically on bulk
samples using the fluorescent fatty acid binding protein ADIFAB to assess the total amount of
hydrolysis occurring during incubation with sPLA2 (Fig. 3-4A). Consistent with previous reports,
the control cells displayed transient hydrolysis detected by ADIFAB indicative of a small subset
of cells (10–15% of the sample based on Figs.3- 2 and 3-3) that were compromised in culture or
during sample preparation and therefore became vulnerable to the enzyme (Olson et al., 2010).
After treatment with TG, the amount of lipid hydrolyzed was 52% of the total achieved when
100% of the cells are susceptible to the enzyme (Fig. 3-4C, green bar).
Previous reports have indicated that the total number of cells vulnerable to sPLA2 can
also be quantified by counting the number stained by MC540 (Bailey et al., 2009; Bailey et al.,
2007). Accordingly, we also assessed MC540 staining by flow cytometry (Fig. 3-4B).
Quantitatively, the number of cells staining brightly for MC540 in control and TG samples
(violet bars, Fig. 3-4C) matched the percentage hydrolyzed (green; see statistical details in the
legend to Fig. 3-4).

Comparison between hydrolysis and propidium iodide uptake for various inducers of cell death
The purpose for obtaining these two estimates of the number of cells vulnerable to
enzymatic attack was to compare to the propidium iodide flow cytometry results and identify
those populations of cells likely to be targets for sPLA2. For control samples and those treated
with TG, the positive (blue) and intermediate (red) populations were adequate to account for the
amount of hydrolysis and the apparent numbers of susceptible cells (Fig. 3-4C). As predicted by
the data in Fig. 3-3D (red curve), the amount of hydrolysis was less than the sum of the
intermediate and positive populations (p < 0.001). In contrast, cells treated with DEX exhibited a
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greater amount of hydrolysis than could be explained by flow cytometry assessments of MC540
fluorescence or PI permeability (p < 0.01). This result implies that either there is a greater
amount of lipid hydrolyzed per cell, or some of the negative propidium iodide population (gray)
is hydrolyzed at a rate low enough that it does not produce enhanced permeability to propidium
iodide. One way in which the first of these possibilities could be realized is that cells treated with
DEX, but not TG or ionomycin, may break into fragments during hydrolysis that exposes
additional intracellular membranes to sPLA2. Further experiments will be required to resolve this
difference and to identify the extent to which it is a common feature among various apoptotic
stimuli.
Cells induced to die by brief treatment (10 min) with a calcium ionophore, ionomycin,
also behaved differently. In this case, all the cells were vulnerable to the enzyme and stained
brightly for MC540 as reported previously (Bailey et al., 2007). However, only about 30% of the
cells sorted into the positive or intermediate propidium iodide populations by flow cytometry,
indicating that most of the hydrolysis observed with ionomycin-treated samples originates from
cells that exclude propidium iodide completely.

Comparisons among sPLA2 isoforms
To test the potential physiological relevance of these findings, we compared the relative
abilities of three human isoforms of sPLA2 to hydrolyze samples using data obtained with the
AppD49 enzyme as a standard. We compared initial rates rather than total hydrolysis amounts
because they more readily resolve quantitative differences related to enzyme activity. Figure 3-5
summarizes the initial rate of hydrolysis for all four isozymes under various experimental
conditions. As suggested by Fig. 3-4A, the initial rate catalyzed by AppD49 toward TG-treated
cells was similar to that observed for unhealthy cells in the control sample (p > 0.05) even
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though the total available substrate was very different (Fig. 3-5A). Dexamethasone induced
susceptibility to sPLA2 at a slightly higher initial rate that was distinguishable from that observed
toward damaged cells in the control sample (p < 0.05). As shown in prior studies, the rate toward
ionomycin-treated samples was much greater than with any of the other conditions (p < 0.01
compared to DMSO) (Bailey et al., 2007; Olson et al., 2010). A similar pattern was obtained
with the hGX isoform toward the weakened population in control samples and toward cells
treated with the various inducers of cell death (Fig. 3-5B). In this case, only the ionomycin group
was statistically different from the control group (p < 0.01). In contrast to the results with the
AppD49 and hGX isozymes, the hGIIa and hGV isozymes generally showed a different pattern
with more obvious differences in the rate of hydrolysis between control and apoptotic samples
(TG and DEX) but diminution of the rate toward samples incubated briefly with ionomycin
(Figs. 3-5C and D; see legend for statistical details). As explained for the AppD49 isoform, the
amount of lipid hydrolyzed in the various treatment groups was always much greater than
observed in the control sample (reflecting the larger number of cells participating in
biochemically-programmed death) even though the initial rate was sometimes comparable
(Bailey et al., 2007).
The lower activity of hGIIa toward mammalian cell membranes has been reported
previously (Beers et al., 2002; Bezzine et al., 2002; Birts et al., 2010; Boyanovsky and Webb,
2009) and probably relates to the absence of tryptophan at its interfacial binding surface (Baker
et al., 1998; Beers et al., 2003; Bezzine et al., 2002). This difference was not due to low activity
of the enzyme preparation since hGIIa was the most active of the four toward the DPPG
liposomes used as a positive control (AppD49 = 0.05 GP units·s-1, hGIIa = 0.08 GP units·s-1,
hGV = 0.005 GP units·s-1, hGX = 0.01 GP units·s-1). This dichotomy between hGIIa activities
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toward liposomes versus apoptotic cells probably reflects the much higher density of negative
charge on the liposome compared to that achievable in S49 cells (Wilson et al., 1999).

Discussion
The data in this study argue strongly that one consequence of the modest increase in
membrane permeability detected by propidium iodide as an intermediate-staining population is
enhanced susceptibility to hydrolysis by sPLA2. Moreover, this enhanced susceptibility is likely
to have physiological significance because several sPLA2 isoforms present in human plasma
responded to these early apoptotic cells (Fig. 3-5). In contrast, cells dying by ionophore
treatment showed two important deviations from this pattern. First, the cells did not display a
sizeable intermediate-staining propidium iodide population even though they stained brightly
with MC540 and were aggressively attacked by AppD49 and hGX sPLA2. Second, the
ionophore-treated cells were hydrolyzed at a much lower rate by hGV and hGIIa sPLA2. This
second observation was reported previously and raised the question of whether there might be
differences in physical properties of the membranes of apoptotic and ionophore-treated cells that
explain this apparent specificity of the isozymes (Olson et al., 2010). The presence of anionic
lipids such as phosphatidylserine on the membrane surface and enhanced spacing of bilayer
lipids, two properties known to be relevant to the activity of these enzymes, were excluded as
candidates since both are expressed more completely in ionophore-treated cells than in those
undergoing apoptosis (Fig.3-4 and (Olson et al., 2010)). However, the relationship between
hydrolysis and the intermediate-staining propidium iodide population discovered here (Figs. 3-4
and 3-5) is a match with the prior observations and may explain the specificity of hGV and hGIIa
sPLA2 isoforms toward apoptotic cells.
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This result begs the interesting question: what is the molecular source of the
intermediate-staining population, and why does it appear to relate to enhanced enzymatic activity
of hGIIa and hGV sPLA2 isoforms? An attractive possibility is that both events are produced by
lipid oxidation. This idea stems from three published observations. First, lipid peroxidation
appears to occur during apoptosis, perhaps catalyzed by cytochrome c oxidase released from
mitochondria (Greenberg et al., 2008; Tyurin et al., 2009; Tyurin et al., 2008b; Tyurina et al.,
2000). Second, studies with artificial bilayers suggest that lipid oxidation can perturb the
physical properties of membranes in ways that enhance their permeability (Greenberg et al.,
2008; Howland and Parikh, 2010; Smith et al., 2009; Yajima et al., 2009). Third, membranes
containing oxidized lipids are more vulnerable to hydrolysis by sPLA2, especially the hGIIa
isozyme (Akiba et al., 1997; Korotaeva et al., 2010; Korotaeva et al., 2009a; Korotaeva et al.,
2009b; McLean et al., 1993).
A second possibility relates to studies with artificial membranes demonstrating that
fluctuations caused by changes in membrane order and fluidity can permit charged molecules
like propidium iodide to temporarily traverse the bilayer (Apellaniz et al., 2010; Deamer and
Bramhall, 1986; Freire and Biltonen, 1978; Marsh et al., 1976; Wilson-Ashworth et al., 2004).
The increased staining of the membrane by MC540 (Fig.3- 4 and Ref. (Bailey et al., 2009; Bailey
et al., 2007)) probably also represents changes of that nature (Ashman et al., 1995; Mower et al.,
1994; Stillwell et al., 1993; Stott et al., 2008; Wilson-Ashworth et al., 2006). Thus, it may be that
the intermediate propidium iodide population does not represent emergence of an additional
membrane physical trait but instead, greater magnitude of the same perturbations detected by
MC540. In other words, perhaps MC540 is sensitive to low levels of perturbation as perhaps
occurs with ionomycin. When the perturbation escalates to also become detectable by propidium
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iodide, such as during apoptosis, there is no additional staining by MC540 because the intensity
was already maximal at a weaker perturbation. If this is true, then the differences among
isoforms with respect to membrane physical properties would be quantitative rather than
qualitative and could be summarized as follows.
1. Cells that are negative for both MC540 and propidium iodide were not attacked by any of
the sPLA2 isoforms studied here.
2. Cells that are weakly perturbed, as during ionomycin treatment, stain brightly by MC540
but are still negative for propidium iodide. These cells were good substrates only for the
AppD49 and hGX isoforms.
3. Cells that are more strongly perturbed stain brightly by MC540 and at an intermediate
level with propidium iodide. These cells were observed during apoptosis and were
susceptible to all four isoforms.
4. The cells that are most heavily perturbed are positive for both propidium iodide and
MC540. A previous study demonstrates these cells are also hydrolyzed by the various
isozymes, at least during mid-apoptosis (Olson et al., 2010).
Finally, there is evidence that membrane permeability is enhanced in a more specific
fashion early during apoptosis via pannexin 1 channels (Chekeni et al., 2010). This rise in
permeability allows release of nucleotides such as ATP and UTP from apoptotic cells. These
nucleotides function as signals to attract macrophages in preparation for clearance of apoptotic
remnants (Chekeni et al., 2010; Chekeni and Ravichandran, 2011). Whether activation of these
channels accounts for the modest rise in permeability to propidium iodide is unknown. Other
vital stains such as YO-PRO-1 and TO-PRO-3 appear to be conducted by pannexin channels, but
propidium iodide was reported not to stain cells at a stage of apoptosis when pannexin channels
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are open (Chekeni et al., 2010). Unfortunately, the experimental data were not reported in
sufficient detail to allow one to ascertain whether the more moderate propidium iodide diffusion
characteristic of early apoptotic cells could be explained by pannexin channel activation.
Moreover, it is unclear how pannexin channel activation might relate directly to increased
vulnerability of the membrane to hydrolysis by sPLA2.
The data in this study suggest the possibility that the temporary moderate increase in
membrane permeability during apoptosis could have significant consequences because these
cells can be hydrolyzed by pro-inflammatory enzymes present in the plasma. In general, it is
thought that this kind of problem would be avoided through elimination of apoptotic cells by
macrophages (Peter et al., 2010a; Peter et al., 2010b, c). The issue, then, becomes one of timing.
Recent studies have suggested that macrophage participation involves two signals: a recognition
or “find-me” signal followed by an “eat-me” signal (Chekeni et al., 2010). The first appears to
involve increases in membrane permeability via the pannexin 1 channel mentioned above
(Chekeni et al., 2010). The second is the exposure of phosphatidylserine on the external face of
the cell membrane (Callahan et al., 2000; Fadeel, 2004; Krahling et al., 1999; Verhoven et al.,
1995). Since the hGV and hGIIa isoforms require the presence of phosphatidylserine in addition
to enhanced membrane permeability, they would not be capable of generating inflammatory
precursors until the “eat-me” signal and the resulting protection by phagocytosis. Therefore,
these isoforms are unlikely to produce an untoward inflammatory response. However, as recently
demonstrated, the hGX isozyme actively hydrolyzes the cell membrane during apoptosis prior to
the exposure of phosphatidylserine (Olson et al., 2010). Accordingly, the potential exists for
production and release of inflammatory fatty acids and lysophospholipids during apoptosis
before the dying cells can be cleared by macrophages. This scenario may not be
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disadvantageous, however. Although pannexin channel activation has been proposed as one
mechanism for releasing certain “find-me” signals, additional molecules that fulfill the same
function have also been reported to be released during early apoptosis through undetermined
means (Peter et al., 2010a; Peter et al., 2010b, c). Among those other signals is
lysophosphatidylcholine (Lauber et al., 2003; Mueller et al., 2007; Peter et al., 2008). It is thus
tempting to speculate that hGX sPLA2 may play a major role in releasing
lysophosphatidylcholine as a “find-me” signal through mechanisms described in this study.
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Figure 3-1: Contour plots of propidium iodide fluorescence and forward light scatter.
Samples were stained for 10 min with propidium iodide in Panel A and fluorescence intensity and
forward light scatter were assessed for individual cells by flow cytometry. In Panels B–D, cells were
stained for 1 min (B), 5 min (C), or 10 min (D) with propidium iodide prior to immediate flow cytometry.
Labels: “N”, negative (same as background); “I”, intermediate propidium iodide staining; “P”, positive or
complete propidium iodide staining.
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Figure 3-2: Histograms of propidium iodide fluorescence intensity before and after hydrolysis
by sPLA2.
Cells were treated with DMSO (Panel A) or TG (Panel B). Samples were stained for at least 10 min
with propidium iodide without (black curves) or with (red curves) AppD49 sPLA2. Fluorescence
intensity per cell was assessed by flow cytometry. Histograms were smoothed by nonlinear
regression using multiple Gaussian functions. Labels: “N”, negative (same as background); “I”,
intermediate propidium iodide staining; “P”, positive or complete propidium iodide staining.
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Figure 3-3: Time course of distribution of cells among populations defined by propidium iodide
fluorescence intensity before and after hydrolysis by sPLA2.
Panel A: data from three independent experiments such as that shown in Fig. 2 were quantified at the
indicted time points following mixing with propidium iodide—black, percentage of the cell sample
staining negative for propidium iodide intensity (see field marked “N” on Fig. 2); red, intermediate for
propidium iodide (“I” on Fig. 2); blue, propidium iodide positive (“P” on Fig. 2). Panel B: The
experiments and analysis of Panel A were repeated for samples incubated with sPLA2 simultaneously
during the propidium iodide staining. Panel C: The data represent the differences between Panels A and
B. Panel D: Histograms of the intermediate peak corresponding to the last time point from one of the
samples in Panels A–C for cells without sPLA2 (black), with sPLA2 (red), and the arithmetic difference
between the two (blue). Data were fit by nonlinear regression to a Gaussian function. The brackets
represent the 95% confidence intervals for the fitting parameter corresponding to the mean values.
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Figure 3-4: Comparison of compartment sizes assessed by various methods for cells treated with
TG, DEX and ionomycin.
Panel A: Time profile of membrane hydrolysis by AppD49 sPLA2 (dotted line) assayed with ADIFAB as
explained in Materials and Methods (DMSO: black, TG: red). Panel B: Flow cytometry histograms of
MC540 staining for cells treated with DMSO (black) or TG (red). Panel C: Cell compartment sizes were
estimated by spectroscopy or flow cytometry and normalized to maxima. Green bars: total amount of lipid
lipid hydrolyzed by sPLA2 in 300 s (as in Panel A). Orange bars: number of cells permeable to propidium
iodide prior to addition of sPLA2 (spectroscopy). Brown bars: number of cells staining hypodiploid for
propidium iodide due to fragmented DNA (flow cytometry). Yellow bars: number of cells excluding
propidium iodide but permeabilized within 300 s by sPLA2 (spectroscopy). Violet bars: number of cells
staining positive for MC540 (flow cytometry, as in Panel B). Blue, red, and gray bars: number of cells
staining positive, intermediate, and negative for propidium iodide (flow cytometry as in Figs. 1–3). Error
bars represent SEM (n = 3–42). The four sets of observations representing hypothesized sPLA2susceptible cohorts (green, orange + brown + yellow, violet, and blue + red) were compared to each other
by one-way analysis of variance separately for DMSO, TG, and DEX treatments. All three analyses were
significant (p < 0.02). Dunnett’s post test comparing each cohort to the corresponding hydrolysis group
(green) was conducted. For DMSO, none of the cohorts was different from hydrolysis. For TG, the flow
cytometry (blue + red) cohort was statistically different (p < 0.01). For DEX, all cohorts except MC540
(violet) were statistically significant compared to hydrolysis (p < 0.05).
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Figure 3-5: Comparison of initial hydrolysis rates catalyzed by snake venom and human sPLA2
isoforms among cells treated with DMSO, TG, DEX, or ionomycin.
Hydrolysis was measured by ADIFAB fluorescence as in Fig. 4A for cells treated as indicated. The initial
rate was quantified as described in Materials and Methods. Panel A: AppD49; Panel B: hGX; Panel C:
hGV; Panel D: hGIIa. For the AppD49, hGX, and hGIIa isozymes, the results were significant by oneway analysis of variance (p < 0.008). As indicated by Dunnett’s post-test, the following treatments were
statistically different from the corresponding DMSO controls (p < 0.05): AppD49—DEX and ionomycin,
hGX—ionomycin, hGIIa—DEX.
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CHAPTER 4: ROLE OF MEMBRANE OXIDATION IN CONTROLLING THE ACTIVITY
OF HUMAN GROUP IIA SECRETORY PHOSPHOLIPASE A2 TOWARD
APOPTOTIC LYMPHOMA CELLS

Introduction
Recently, we have focused on the relationship between apoptosis and the activity of
various isoforms of sPLA2. Numerous studies have identified two physical changes as being
relevant to the action of sPLA2 during cell death: 1) an increase in the presence of anionic
phospholipids (generally phosphatidylserine, PS) in the outer leaflet of the membrane (Bezzine
et al., 2002; Harris et al., 2001; Koduri et al., 1998; Murakami et al., 1999; Olson et al., 2010;
Singer et al., 2002; Smith et al., 2001) and 2) a decrease in membrane lipid order reflecting
diminished strength of interactions among adjacent phospholipids (Best et al., 2002; Harris et al.,
2001; Heiner et al., 2008; Jensen et al., 2005; Olson et al., 2010). In addition, studies with
calcium ionophore-stimulated death indicated that a third membrane alteration must be essential
for the human group IIa isoform (hGIIa) of the enzyme (Nelson et al., 2011; Olson et al., 2010).
Even though ionophore-stimulated calcium uptake caused immediate full exposure of PS and
maximal reduction in lipid order, hGIIa sPLA2 did not hydrolyze the cell membrane. These
observations strongly contrasted the response of the enzyme to artificial membranes composed
entirely of anionic phospholipids (Bezzine et al., 2002; Buckland and Wilton, 1998; Kinkaid and
Wilton, 1995; Nelson et al., 2011; Olson et al., 2010; Singer et al., 2002). Furthermore, a
different isoform, hGX, hydrolyzed ionophore-treated cells at a greater rate than apoptotic cells
and appeared not to require a third factor (Olson et al., 2010).
A recent publication reported that some apoptotic inducers produce a subpopulation of cells with
slight permeability to propidium iodide (Nelson et al., 2011). This modest permeability
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correlated with increased susceptibility to the hGIIa isozyme. That study suggested that plasma
membrane oxidation could be a candidate for the third membrane alteration mentioned above
(Nelson et al., 2011). This hypothesis is supported by three observations. First, cytochrome c
release during apoptosis causes lipid oxidation (Fabisiak et al., 1998; Greenberg et al., 2008;
Jiang et al., 2004; Tyurin et al., 2009; Tyurin et al., 2008a; Tyurina et al., 2000). Second, lipid
oxidation enhances the permeability of artificial bilayers (Greenberg et al., 2008; Howland and
Parikh, 2010; Smith et al., 2009; Yajima et al., 2009). Third, membranes containing oxidized
lipids are more susceptible to hydrolysis by the hGIIa isoform of sPLA2 (Akiba et al., 1997;
Korotaeva et al., 2010; Korotaeva et al., 2009a; Korotaeva et al., 2009b; McLean et al., 1993).
We have therefore tested the hypothesis that membrane oxidation is the third factor required for
a membrane to become susceptible to hydrolysis by hGIIa sPLA2. Accordingly, we assayed lipid
oxidation potential of S49 lymphoma cells during death triggered by TG, an inhibitor of the
endoplasmic reticulum Ca2+ ATPase that causes ER stress (Feng et al., 2006; Kass and Orrenius,
1999; Yoshida et al., 2006). Activity of hGIIa sPLA2 was then assayed to determine if
susceptibility correlated with membrane oxidation. Cell membranes were then directly oxidized
using tert-butyl hydroperoxide (TBHP) or 2,2'-azobis-2-methyl-propanimidamide,
dihydrochloride (AAPH, a hydrophilic radical initiator), and hydrolytic activity of hGIIa sPLA2
was determined. Externalization of PS and lipid order were also assessed to establish which of
these membrane changes is necessary for hGIIa sPLA2 activity.

Results
A fluorescent lipid analog, C11-BODIPY581/591, was used to assess the lipid oxidative
potential of cell membranes after treatment with TG (Drummen et al., 2002). As shown in Fig. 41, confocal microscopy revealed that C11-BODIPY581/591became oxidized (green) after TG
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treatment (Panel B) compared to control cells (Panel A). The percentage of the cell population
that contained oxidized C11-BODIPY581/591 was quantified using flow cytometry after different
lengths of incubation with TG to determine the temporal onset of lipid oxidation (Panel C).
Maximum oxidation did not occur until after 4.5 h with TG.
Previous reports demonstrated that the activity of the hGIIa isozyme is enhanced during
apoptosis, including that stimulated by TG (Nelson et al., 2011; Olson et al., 2010). However,
even though the enhancement was significant compared to the undetectable hydrolysis of
quiescent cells, it was dwarfed by that catalyzed by other sPLA2 isozymes (Nelson et al., 2011;
Olson et al., 2010). Compared to a standard for full activity (hydrolysis of
dipalmitoylphosphatidylglycerol liposomes), human groups V and X isozymes were 31 ± 2 and
58 ± 7% of that maximum when hGIIa was only 0.46 ± 0.09% (Nelson et al., 2011; Olson et al.,
2010). In the case of TG-induced apoptosis, these measurements were obtained at 3-h treatment
with TG, a time point at which the activity of the other sPLA2 isozymes toward apoptotic cells is
maximal (Nelson et al., 2011). However, Fig. 4-1 shows that oxidation is a later event in TGinduced death. Therefore, to explore the possible role of oxidation, hGIIa sPLA2 activity was
compared between 3 and 5 h incubation with TG (Fig. 4-2A). The initial hydrolysis rates from
multiple replicates are represented as gray bars in Fig. 4-2B and overlaid with PS externalization
(dashed curve; data from ) and C11-BODIPY581/591 oxidation (solid curve; data from Fig. 4-1C).
Although significant activity was detectable at 3 h, it increased 30-fold at 5 h.
To further validate the possibility that membrane oxidation is the key factor required for
this isozyme, chemical oxidizing agents were used to directly cause lipid oxidation (Fig. 4-3).
Confocal microscopy with C11-BODIPY581/591 was used to verify that the plasma membrane
becomes oxidized after treatment with TBHP (60 min; Panel B compared to Panel A) and AAPH
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(15 h; Panel D compared to Panel C). In both cases, oxidation was widespread among the cells.
In contrast, treatment of the cells with ionomycin, which renders them fully susceptible to some
sPLA2 isozymes, such as human group X, but not hGIIa (Olson et al., 2010), did not result in
appreciable oxidation (Panels E and F). Figure 4-4A demonstrates that the two agents that caused
membrane oxidation also stimulated hydrolysis by hGIIa. In fact, the rates were substantially
higher than that observed with 5 h TG (2.5–3-fold greater). Control experiments with TBHP in
the presence of antioxidants (trolox or NecroX-5™) demonstrated that the results depended on
oxidation rather than artifactual effects of the agent.
As mentioned above, decreased lipid order and exposure of phosphatidylserine have been
linked to high sPLA2 activity. Therefore, these two membrane changes were assayed after
treatment with TBHP and AAPH. Lipid order was assessed with three different fluorescent
probes: MC540, TMA-DPH, and Patman. As shown in Fig. 4-4B, TBHP treatment caused an
increase in MC540 fluorescence comparable to that caused by TG (Chapter 5). This effect has
been shown previously to reflect a decrease in lipid packing density in the plasma membrane
pursuant to a reduction in bilayer order (Bailey et al., 2009; Bailey et al., 2007; Stillwell et al.,
1993). Likewise, TBHP caused a decrease in the value of TMA-DPH anisotropy similar to the
result with TG (Fig. 4-4C). In contrast, effects of TBHP on Patman fluorescence were less than
half that observed with 5 h TG treatment (Fig. 4-4D). The results with AAPH differed
substantially from those with TBHP. Although it was equal or better at promoting hydrolysis
compared to TBHP, it was much weaker at promoting changes in membrane order detected by
Patman or MC540 (black bars, Figs. 4-4B and D). Interestingly, TMA-DPH anisotropy was
altered by AAPH to a level comparable to that induced by the other agents (Fig. 4-4C).
Externalization of PS (annexin V binding) was assayed by flow cytometry. Both TBHP and
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AAPH induced PS exposure, as expected (Piga et al., 2007; Sardao et al., 2007), although the
effects tended to be smaller and more variable than experienced in S49 cells with apoptotic
agents such as TG or glucocorticoid (TBHP: 37.7 ± 9.6% increase in annexin-positive cells,
AAPH: 39.0 ± 13.2% increase, TG: 85.6 ± 0.7% increase , glucocorticoid: 83.7% increase
(Bailey et al., 2009)).

Discussion
We concluded, based on these results, that oxidation is likely to be the source of the
“third membrane alteration” postulated previously (Nelson et al., 2011) as described in the
Introduction. However, the data of Figs. 4-4B–D indicate that all three alterations are not
simultaneously required for the membrane to experience a high level of hydrolysis. Specifically,
the reduction in membrane order, thought previously to be critical, was not necessary when
oxidation had occurred. To test whether this effect was confined to hGIIa, we repeated the
hydrolysis experiments of Fig. 4-4A toward AAPH-treated cells with a generic snake venom
sPLA2 for which the role of membrane order is prominent and well established (Bailey et al.,
2009; Bailey et al., 2007; Bell and Biltonen, 1989; Bell et al., 1996; Henshaw et al., 1998; Olson
et al., 2010). Treatment with AAPH stimulated hydrolysis by the snake venom isozyme to an
extent similar to that observed when membrane order changes and PS exposure have occurred in
the absence of oxidation (110 ± 23% of the activity observed at 3, 5 h TG treatment, n = 4). This
result suggests that oxidation of the membrane can replace the need for alterations of membrane
order by promoting the same step in the hydrolysis reaction scheme. In fact, the data for hGIIa
argue that oxidation is more effective. Chapter 5 demonstrates quantitatively that the change in
membrane order is likely to enhance hydrolysis by increasing the probability that individual
phospholipids in the bilayer can spontaneously protrude to an extent sufficient to enter
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the active site of adsorbed sPLA2 . Although oxidation of membrane lipids does not necessarily
alter overall membrane physical properties in the same way as observed during apoptosis
(compare patterns of TBHP and AAPH with TG results in Figs. 4-4B–D), other structural
analyses have identified an alternative hypothesis that may explain how this chemical alteration
could increase phospholipase activity (Catala, 2012; Greenberg et al., 2008; Khandelia and
Mouritsen, 2009). This “lipid whisker hypothesis” describes a dominant conformation of
oxidized phospholipids in which the altered fatty acid tail extends out from the membrane
surface into the aqueous phase. Thus, the lipid is positioned in the bilayer with one tail immersed
normally and the other extended in the opposite direction. This altered conformation might allow
entry of the extended acyl chain into the enzyme active site without need for vertical protrusion
of the phospholipid (Greenberg et al., 2008; Hazen, 2008). Although the data of this paper do not
prove that idea, they are consistent with it. Future experiments identifying directly the specific
substrates for sPLA2 during apoptosis will be needed to validate this idea further.
The ability of oxidation to replace the need for a change in membrane order begs the
question of whether exposure of anionic lipids such as PS on the exterior of the cell is still
necessary for hGIIa after oxidation. This question cannot be answered definitively with the data
obtained here since all treatments that produced oxidation also caused exposure of PS. This
result may corroborate earlier findings that oxidation of phospholipids creates a means of both
enzymatic and non-enzymatic transfer of PS to the outer leaflet of the cell membrane (Tyurina et
al., 2004; Volinsky et al., 2011). Nevertheless, it is well established that the residence time of
hGIIa on a membrane surface is extremely short unless anionic lipids are also present.
Measurements of adsorption of hGIIa sPLA2 to artificial membranes by a centrifugation assay
revealed that the apparent association constant increased from undetectable for a 10%
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PS/phosphatidylcholine mixture to 5000 M–1 in a 30% mixture (Singer et al., 2002). Likewise,
the rate of hydrolysis of a pure anionic membrane is 300-fold greater than that observed toward a
zwitterionic bilayer (Singer et al., 2002). The reason for this significant effect is clear upon
considering the structure of the interfacial binding surface of hGIIa. It is highly enriched in
cationic residues and devoid of trp residues present on the interfacial adsorption surface of other
sPLA2 isozymes that act more effectively on zwitterionic membranes (Baker et al., 1998; Beers
et al., 2003; Diraviyam and Murray, 2006; Han et al., 1999; Snitko et al., 1997).
Some of the products of phospholipid oxidation are also anionic, with carboxylic acids on
fatty acid chains broken by the introduction of peroxides. Based on the lipid whisker hypothesis,
these carboxylic acids would be exposed on the membrane surface where they could interact
with sPLA2. Thus, it seems plausible that oxidation would assist adsorption of the enzyme
directly in addition to its effect to enhance the ability of affected phospholipids to enter the active
site of sPLA2. Nonetheless, it is likely that this contribution of lipid oxidation would be relatively
small since many oxidation products are not charged. Thus far, to the authors’ knowledge, no
evidence for improved adsorption of hGIIa to bilayers composed of oxidized lipids has been
reported, and experiments to test that idea are therefore needed. Regardless, the adsorption
potential of hGIIa is still not fully realized with mammalian cells even with the combined effects
of PS exposure and lipid oxidation. For example, we found that hGIIa hydrolyzes liposomes of
pure anionic phospholipid (dipalmitoylphosphatidylglycerol) analogous to bacterial membranes
at a 4-fold higher rate than oxidized mammalian cell membranes (comparing average of TBHP
and AAPH data of this paper to standards reported by us in previous studies (Nelson et al., 2011;
Olson et al., 2010)).
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Much of what is known about phospholipid oxidation and sPLA2 comes from studies of
lipoproteins. The heightened action of hGIIa toward oxidized lipoproteins has been proposed as a
major action of the isozyme with significant implications for the pathology of atherosclerosis
(Korotaeva et al., 2009a; Leitinger et al., 1999; Pruzanski et al., 1998). The potential for similar
responsiveness of hGIIa toward cell membranes that have become oxidized during apoptosis or
other traumatic events had not received comparable attention. Here we show that that potential is
real and merits further investigation. Although the focus here was on the hGIIa isozyme,
preliminary results with snake venom sPLA2 raise the possibility that other isozymes may
respond similarly to oxidation. At least some of these other isozymes, such as group X and group
V, respond to other membrane changes such as decreased lipid order and PS exposure to a
greater extent than hGIIa in the absence of oxidation (Olson et al., 2010). Thus, different forms
of cell damage as well as different moments along the time course of programmed cell death will
capacitate different sPLA2 isozymes depending on the types and relative amounts of membrane
changes occurring. For example, early in some forms of apoptosis, the membrane becomes
susceptible to group X sPLA2 prior to significant PS exposure and oxidation (Nelson et al., 2011;
Olson et al., 2010). As shown in this study, hGIIa will attack those cells later in the process when
oxidation initiated in the mitochondria has spread to the plasma membrane. Physiologically, this
secondary attack by hGIIa should be forestalled by phagocytosis of apoptotic cells activated by
exposure of oxidized PS (Greenberg et al., 2006; Kagan et al., 2002). Nevertheless, in other
conditions in which membrane oxidation is prevalent, such as certain neurodegenerative diseases
(Lee et al., 2011; Sun et al., 2005), the action of hGIIa and other sPLA2 isozymes may be
substantial, leading to death of affected cells and untoward release of proinflammatory fatty
acids and lysophospholipids.
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Figure 4-1: Plasma membrane oxidation during TGinduced apoptosis.
Lipid oxidative potential of the membrane was assessed by
confocal microscopy (Panels A, B) and flow cytometry
(Panel C) using C11-BODIPY581/591. Probes fluorescing
green represent those that have been oxidized. Panel A:
control cells. Panel B: cells treated with TG for 4.5 h.
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Figure 4-2: Membrane hydrolysis by hGIIa sPLA2 during TG-stimulated apoptosis.
Panel A: Time profile of membrane hydrolysis after addition of hGIIa sPLA2 (dotted line) in cell
samples treated 3 h (black) or 5 h (gray) with TG. Panel B: Initial rates of hydrolysis (gray bars)
were calculated from data like those in Panel A. The error was ≤ 0.0001 GPADIFAB units (n = 2–4),
which is difficult to discern visually in the graph. Overlays show timing of PS exposure (dashed
curve) and membrane oxidation (solid curve) assayed by flow cytometry (AlexaFluor-labeled
annexin V and C11-BODIPY581/591, respectively).
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Figure 4-3: Confocal microscopy images of membrane oxidation in cells treated with TBHP, AAPH,
or ionomycin.
See Fig. 1 for fluorescence details. Panels A, C, E: Relevant vehicle controls matched with the treatment
samples in Panels B, D, and F. Panel B: 60 min TBHP; Panel D: 15 h AAPH; Panel F: 9 min ionomycin.
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Figure 4-4: Effects of TBHP and AAPH on hydrolysis by sPLA2 and on membrane order.
Panel A: Initial hydrolysis rates were calculated from data like those in Fig. 2A for samples treated 3 or 5
h with TG, at least 21 min with TBHP, or at least 14 h with AAPH. Parallel samples were assessed for
MC540 fluorescence (Panel B), TMA-DPH anisotropy (Panel C), or Patman GP (Panel D). Differences
among treatment groups were significant by one-way analysis of variance (p < 0.016) for Panels A, B,
and D (n = 2–8 per group).
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CHAPTER 5: MOLECULAR DETAILS OF MEMBRANE FLUIDITY CHANGES
DURING APOPTOSIS AND RELATIONSHIP TO
PHOSPHOLIPASE A2 ACTIVITY

Introduction
Secretory phospholipase A2 (sPLA2) is an enzyme which adsorbs to the cell surface and
hydrolyzes phospholipid acyl chains in the sn-2 position, yielding lysophospholipid and fatty
acid (often arachidonic acid). Moreover, sPLA2 is a model protein for studying enzymatic
activity at a lipid-water interface. Interestingly, all cell membranes are not equally susceptible to
hydrolysis by sPLA2. Healthy cells resist hydrolysis by this enzyme whereas apoptotic or
damaged cells become susceptible (Atsumi et al., 1997; Bailey et al., 2007; Nielson et al., 2000;
Wilson et al., 1999). Studies have suggested that perturbations to the bilayer cause changes in the
physical properties of the membrane, allowing individual lipids to migrate into the enzyme’s
active site and become hydrolyzed (Bailey et al., 2009; Bailey et al., 2007; Best et al., 2002;
Harris et al., 2001; Jensen et al., 2005; Smith et al., 2001).
Attempts to understand this differential susceptibility have emphasized changes that
occur in the plasma membrane during apoptosis. Three relevant changes have been described,
but all are not equally understood. The most well-defined change is externalization of
phosphatidylserine (PS), which is sequestered in the inner leaflet of the lipid bilayer in healthy
cells. The thought is that the negative charge of exposed PS facilitates adsorption of sPLA2 to the
membrane surface (Harris et al., 2001; Murakami et al., 1999; Olson et al., 2010). Accordingly,
many studies have demonstrated that sPLA2 has higher activity toward anionic compared to
zwitterionic synthetic membranes (Bezzine et al., 2002; Diraviyam and Murray, 2006; Jain et al.,
1989; Kinkaid and Wilton, 1995; Scott et al., 1990; Yu et al., 2000). A second property
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correlating with sPLA2 activity is increased membrane permeability (Nelson et al., 2011). The
mechanistic basis of this relationship is not yet understood and will not be addressed in this
paper. The third alteration has been suggested by studies utilizing fluorescent membrane probes
such as MC540, Laurdan, and diphenylhexatriene (DPH) (Bailey et al., 2009; Bailey et al., 2007;
Harris et al., 2001). These modifications appear necessary for membrane susceptibility to sPLA2,
but they are vaguely defined as changes in “membrane fluidity” and “order.” In addition, there
have been challenges in interpreting the results to focus solely on the plasma membrane because
Laurdan and DPH freely enter the cell and interact with intracellular membranes.
These biophysical changes are more specifically defined in this study by assaying Patman
spectral shifts and equilibration kinetics as well as trimethylammonium-DPH (TMA-DPH)
anisotropy during TG-induced apoptosis. Thapsigargin produces endoplasmic reticulum stress by
inhibiting the Ca2+ ATPase, and was chosen because it initiates synchronized cell death on a time
scale amenable to the experiments required for this study. Patman and TMA-DPH are cationic
versions of Laurdan and DPH that have been reported to reside primarily in the plasma
membrane (Kuhry et al., 1983; Williams and Webb, 2000; Zipfel et al., 2003) and therefore
eliminate the ambiguities of probe entering the cell. The experiments with Patman apply work
done in model membranes by Franchino et al. (Franchino et al., 2013). Using vesicles of
different compositions and a quantitative model, they determined that the pattern of equilibration
of Patman reflects different configurations of the probe in the bilayer. They also concluded that
the kinetics reveal dynamic changes in the molecular environment around the probe and can be
used to infer additional biophysical detail beyond what can be gleaned from steady-state
observations. Additionally, another model developed in artificial membranes is utilized here to
estimate the change in phospholipid protrusion density. Patman and TMA-DPH data collected
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during the main phase transition of artificial bilayers with different compositions are also used to
correlate fluorescence observations with the interaction energy among adjacent phospholipids.
The resulting calibration coefficients are then applied to data from living cells to estimate
increases in the probability of lipid protrusions that promote hydrolysis during apoptosis
(Halperin and Mouritsen, 2005; Hoyrup et al., 2004).

Results

Death
A timeline of major apoptotic markers during TG-induced death is shown in Fig. 5-1.
Caspase activation was assessed using the fluorescent pan-caspase inhibitor FAM-VAD-fmk
which enters the cell and irreversibly binds activated caspases. The caspase cascade was
activated in half of the cells (triangles, dashed curve, left panel) and preceded externalization of
PS (circles, solid curve, left panel), trypan blue uptake (inverted triangles, solid curve, right
panel; note the different time scale on the right panel), and DNA fragmentation (squares, dashed
curve, right panel). Likewise, DNA fragmentation was observed in 50% of the cells, although it
was not complete until 7 h after addition of TG. In contrast, 100% of the cells exposed PS in the
outer leaflet of the cell membrane. This exposure was complete after 3 h with TG. However,
only half of the gain in PS exposed in response to TG was preventable by the general caspase
inhibitor, Z-VAD-fmk (42.3 ± 9.2% reduction; p < 0.05; effect of Z-VAD-fmk on control cells
was insignificant; analysis of variance with Bonferroni post-test, n = 5 for all groups). The
proportion of the cell population that was permeable to trypan blue gradually increased, reaching
~85% at 12 h of TG treatment. These results suggested that about half of the cells died by
classical apoptosis although the rest eventually died by another mechanism.
52

Susceptibility to sPLA2
Figure 5-2 illustrates that treatment with TG rendered S49 cells susceptible to hydrolysis
by sPLA2. Fig. 5-2A is a summary of the total amount of membrane hydrolysis after different
incubation times with the apoptotic inducer. Maximal hydrolysis was observed after 3 h with TG.
When the vital stain propidium iodide is included to assess viability concurrently, it is possible to
quantify the subpopulation of cells that is still alive but has progressed far enough into the death
process to be susceptible to sPLA2. As demonstrated previously, these cells exclude the dye until
their membranes are damaged by hydrolysis (Bailey et al., 2009; Nielson et al., 2000). Figure 52B shows that this alive and susceptible subpopulation reached a maximum of about 30% of the
total cell population around 3.5 h. As shown in Fig. 5-2C, about half of this subpopulation was
apoptotic (based on inhibition by Z-VAD-fmk). This proportion of alive but susceptible cells was
large compared to the ~5–8% seen previously with DEX (Bailey et al., 2009; Nielson et al.,
2000), indicating that TG-induced apoptosis is a good model for exploring membrane changes
responsible for susceptibility. At longer time points, this alive but susceptible subpopulation
diminished in size because a larger proportion of the cells were now already permeable to
propidium iodide in the absence of sPLA2. Comparing the shapes of the time profiles in Figs.52A and B demonstrates that the cells continued to be good substrates for sPLA2 after they
become permeable to propidium iodide. Interestingly, the subpopulation of alive and susceptible
cells never reached zero at long incubation times even though all other markers of apoptotic
progression indicate completion of the process for vulnerable cells by ~7 h. This result suggests
that about 10% of the cells progress far enough to become susceptible to hydrolysis but remain
static in that state without completing the death process. The ~10% discrepancy between PS
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exposure and trypan blue uptake shown in Fig. 5-1 supports this conclusion as it illustrates that
there are cells with altered membranes that remain alive up to 12 h.

Probes of membrane biophysics
The strategy we employed to identify the nature of biophysical changes in the cell
membrane associated with enhanced hydrolysis by sPLA2 was to use information from several
membrane probes sensitive to the level of lipid order in the membrane (MC540, Laurdan,
Patman, TMA-DPH and DPH). Figure 5-3 illustrates that TG treatment caused both an increase
in the intensity (Panel A) and red-shift in the peak (Panel B) of the MC540 emission spectrum
compared to vehicle controls (DMSO). These two effects appeared to follow a similar time
course and were maximal by about 5 h. Figure 5-3C indicates that about half of the response was
prevented by treatment with Z-VAD-fmk. Therefore, the cells displaying changes in membrane
physical properties included both apoptotic and non-apoptotic subpopulations, as was observed
in Fig. 5-2C for sPLA2 vulnerability.
Figure 5-4A illustrates that DPH anisotropy increased gradually with TG treatment. As
shown by two-photon microscopy in Fig. 5-4B, DPH distributes rapidly among all membranes in
the cell, thus reporting an average for probe mobility throughout the cell. To isolate effects at the
plasma membrane, we repeated the experiment of Fig. 5-4A with a charged analog of DPH,
TMA-DPH. The trimethylammonium moiety on TMA-DPH is reported to retard diffusion of the
probe into the cells so that it is enriched in the plasma membrane (Kuhry et al., 1983). This
assertion was verified for S49 cells by two-photon microscopy as shown in Fig. 5-4D. Figure 54C demonstrates two major differences between TMA-DPH and DPH anisotropy. First, the
baseline anisotropy differed by 0.16 anisotropy units suggesting a very different mobility in the
plasma membrane compared to the cell interior, a result reminiscent of the higher GP value
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reported for Laurdan at the plasma membrane compared to internal membranes (Bailey et al.,
2009). Second, the temporal trend during TG treatment was sharper and in the opposite direction
compared to DPH. The time scale for the changes in TMA-DPH anisotropy was comparable to
that observed for MC540.
Figure 5-5A illustrates the absence of any distinct pattern in Laurdan fluorescence
assessed spectroscopically in bulk samples with increasing TG incubation time. As explained
previously, interpretation of Laurdan data with cells is confounded by the fact that the probe
rapidly penetrates the plasma membrane and stains the interior as well as the exterior of the cell
(Fig. 5-5B). The problem is mitigated by analyzing images of the fluorescence staining. Twophoton images (Fig. 5-5D) suggested that the average Laurdan GP of the cell perimeter was
different from that of the interior. Figure 5-5C is a quantification of this observation, confirming
the difference between plasma membrane and internal membrane staining and that this difference
changes with TG treatment. Nevertheless, these images cannot distinguish fluorescence
originating from the internal leaflet of the cell membrane versus the external, which is the site of
action of sPLA2.
Patman has essentially the same structure as Laurdan except for a charged moiety
attached to its head (Lakowicz et al., 1983). This modification appears to provide the same
advantage as TMA-DPH, i.e., retaining the probe in the outer leaflet of the cell membrane
(Williams and Webb, 2000; Zipfel et al., 2003). We verified this expectation for S49 cells with
two-photon microscopy as shown in Fig. 5-6A. Figure 5-6B illustrates that Patman GP decreased
with increasing TG incubation time, starting between 1 and 2 h, similar to the time scale
observed with MC540 and TMA-DPH. The data suggest that the maximum response may occur
sooner with Patman compared to the other probes, raising the possibility that the details sensed
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by this probe are especially early in the time course of TG-induced apoptosis. In any case, the
Patman result suggests greater water penetration into the plasma membrane (Parasassi et al.,
1991). At later time points, when the membranes begin to become permeable, the reduction in
Patman GP appeared to partially reverse, perhaps due to probe entering the cell interior.
During Patman data acquisition, an interesting phenomenon was observed; the probe
appeared to equilibrate at different rates when emission was measured at 435 nm compared to
500 nm. These differences are most easily seen by normalizing the data at the two wavelengths
to their own values at 400 s (Fig. 5-7A). As shown in the accompanying paper (Franchino et al.,
2013), this phenomenon also occurs in artificial membranes and may provide additional
information regarding the properties of the bilayer beyond that revealed by the GP alone.
Extraction of that information requires analysis with a quantitative model such as the one
developed in the companion paper (Franchino et al., 2013). That model is employed here.
Accordingly, Patman time courses were smoothed by nonlinear regression using Eq. 5.
The regression curves at 435 (solid) and 500 nm (dashed) were normalized to the intensity of the
435 nm curve at 400 s. This normalization made it possible to aggregate results from multiple
experiments to examine general patterns in shape. Averages of controls, samples treated for 2–5
h with TG, and those treated for 6.5–8 h are shown in Figs. 5-7B, C, and D respectively. The
pattern of Patman equilibration in living cells resembles that observed with vesicles in that they
both represent a sum of two kinetic processes distinguished by rate constants that differ by at
least a factor of 10 (Franchino et al., 2013). Figure 5-8 displays the effects of TG treatment on
the parameters associated with the model (discussed below).
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Discussion
As expected, TG induced apoptosis in S49 cells as seen by caspase activation, PS
exposure, DNA fragmentation, and cell death. These classical events were accompanied by a
previously reported biophysical change in the plasma membrane that correlates with
susceptibility to sPLA2 and precedes cell death. Consistent with other studies of apoptosis,
MC540 emission spectra became red shifted and increased in intensity during TG treatment,
suggesting a reduction in lipid packing (Bailey et al., 2009; Williamson et al., 1983).
DPH and Laurdan have previously been used to investigate changes in membrane fluidity
and order. As a lipid bilayer becomes less fluid and more ordered, movement of DPH becomes
more restricted and its anisotropy increases (Dale et al., 1977; Veatch and Stryer, 1977). Laurdan
is sensitive to the presence and mobility of water molecules near the phospholipid glycerol
backbone (Parasassi et al., 1991). Alignment of water dipoles with that of the excited probe shifts
the emission spectrum (quantified by calculating the GP) to longer wavelengths indicating
greater water penetration into the membrane, presumably allowed by a reduction in phospholipid
order and packing (Harris et al., 2002). As shown in Figs. 5-4B and 5-5B, these two probes
quickly cross the plasma membrane to stain the cell interior, making interpretation difficult. In
addition, their fluorescence properties did not change in a pattern reproducible enough to defend
statistically during the time range when membranes became susceptible to hydrolysis. When the
cell perimeter and interior of two-photon Laurdan images were examined separately, however,
an early trend of decreasing GP was observed. This trend suggested that alterations of the plasma
membrane detected by Laurdan on a time scale relevant to sPLA2 activity do occur (Fig. 5-5C).
To more fully define this biophysical change in the membrane, charged analogues of
DPH and Laurdan, TMA-DPH and Patman respectively, were utilized. As shown in Figs. 5-4D
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and 5-6A, diffusion of these two probes into the cell interior is reduced, validating their direct
use for assessment of plasma membrane properties. The trend in TMA-DPH anisotropy after TG
treatment was substantially different from that of DPH, showing instead a decrease (Fig. 5-4C) at
the same time that membranes were becoming vulnerable to sPLA2 (Figs. 5-2A and B). This
diminished anisotropy implied a reduction in stereo-constraints imposed by neighboring
membrane lipids during early apoptosis, a result consistent with the MC540 data. The concurrent
drop in Patman GP displayed in Fig. 5-6B substantiated this interpretation since a loosening of
neighbor-neighbor interactions would allow increased water penetration into the membrane. The
data at long time points (> 6 h) for Patman suggest that this reduction in lipid order is reversed as
the apoptotic process progresses. The data with TMA-DPH hinted at the same effect, although
the late trend was much smaller than observed with Patman. These results suggest that this
phenomenon is either complex in nature or confounded by membrane blebbing and differential
distribution of these probes during that late time frame. Therefore, at these later time points,
Patman and, to a lesser degree, TMA-DPH could also be staining internal membranes and reflect
the increased order seen with DPH and reported previously for glucocorticoid-induced apoptosis
(Bailey et al., 2009). Moreover, the focus of this study is to understand the nature of membrane
changes facilitating hydrolysis by sPLA2 early in apoptosis before membrane integrity is
compromised. Thus, the remainder of the discussion will focus on changes during the 2–5 h
interval after TG addition.
Further information can be obtained from Patman if equilibration kinetics are examined
in addition to the endpoint GP (Franchino et al., 2013). The same phenomenon shown in Fig. 5-7
was observed in artificial vesicles, and suggested that the probe exists in multiple configurations
in the membrane. One possibility is that the configurations correspond to probe localized in
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different bilayer domains. This possibility was considered and rejected in the accompanying
study (Franchino et al., 2013) for artificial membranes. Molecular dynamics simulations of other
probes with structure related to Patman suggest a second possibility that these configurations
represent different stereo-conformations of the probe (Parisio et al., 2011). Experimental
measurements of Patman fluorescence quenching indicate that they may refer to different depths
in the membrane (Jurkiewicz et al., 2006). For parsimony, only two configurations were
considered here (referred to as “fast” and “slow”, see Ref. (Franchino et al., 2013)) even though
data such as those shown in Ref. (Jurkiewicz et al., 2006) indicated a possible continuum of
Patman locations. With the data gathered thus far, a continuous model cannot be distinguished
from a two-state model in which the observable properties of the states overlap as a function of
the independent variable, in this case wavelength. Regardless of the molecular details of the
configurations, the data in Ref. (Franchino et al., 2013) argue that equilibration of Patman’s
fluorescence represents the local microenvironment relaxing around newly-inserted probe.
By applying the specific model described in the accompanying paper (Franchino et al.,
2013), it was possible to determine which specific parameters were altered with TG treatment.
Figure 5-8 illustrates that TG treatment produced three detectable effects. First, a smaller
proportion of Patman molecules populated the “slow” configuration compared to control cells
(66% compared to 85%, circles, Panel A). To the extent that the “slow” configuration represents
a deeper location in the membrane, the vertical distribution of Patman molecules was skewed
toward shallower depths after TG treatment. Second, the “fast” configuration became more
polar, presumably reflecting the invasion of water molecules into the membrane (triangles, Panel
A). Third, the rate of equilibration slowed for probes in this more polar microenvironment
(diamonds, Panel B).

59

The positioning of Patman in the membrane is probably determined by two factors: the
ability to form a salt bridge between its trimethylammonium and the phosphate of a neighboring
lipid, and the strength of the interactions between Patman’s 16-carbon chain and the surrounding
fatty-acid tails. In the accompanying paper, it was proposed that the “fast” configuration applies
to Patman molecules bonded electrostatically to phospholipid heads and the “slow” configuration
connotes Patman molecules with weaker interactions with the heads and therefore anchored
predominately through the 16-carbon tail (Franchino et al., 2013). The increase of Patman
molecules in the “fast” configuration, then, suggests a weakening of the interactions between the
probe’s hydrophobic tail and neighboring lipids with, perhaps, a net movement of the probe
toward shallower depths.
It was interesting that only the “fast” configuration experienced a change in polarity after
TG treatment. We assume that this polarity increase reflected enhanced water penetration, an
assumption that is well supported (Parasassi et al., 1991). If the two configurations represent
different depths, then only the shallow configuration was influenced by this additional water
penetration. However, fluorescence quenching measurements indicate that the expected
difference in depth is less than an angstrom (Jurkiewicz et al., 2006), smaller than the size of a
water molecule. Thus, if depth is the distinction of the configurations, then the change in polarity
must be localized superficially to both depths so that water’s influence on both configurations is
long-range. The sub-angstrom distinction between configurations must then rely on the sensitive
distance dependency of solvent dipole influences on the fluorophore’s excited state (i.e., d-6),
which would produce large changes in solvent effects with small adjustments to probe location.
The slower equilibration of the “fast” (presumably shallower) configuration implies a
greater diversity of metastable conformations of Patman relative to the molecules comprising its
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local microenvironment such that fluctuations among these conformations delays achievement of
steady state. The presence of that diversity further suggests a lessening of constraints imposed on
the probe by neighboring molecules, allowing greater freedom to sample conformations as
equilibrium is approached. This interpretation is also consistent with the idea that the anchoring
of Patman’s tail among the phospholipid chains has been weakened.
Taken together, the TMA-DPH and Patman results complement the findings with MC540
and suggest that early events in apoptosis produce a membrane that now possesses three new
characteristics. Lipid headgroups are more spaced. The amount and/or depth of water located
among the heads has/have increased. Interactions among lipids in the phospholipid tail region are
reduced so that molecules such as Patman are less tightly anchored to the deep part of the bilayer
and constraints on TMA-DPH motion are lessened.
Based on these interpretations, we are able to explain the increase in phospholipase
activity on the molecular level quantitatively. In order for hydrolysis to occur, a single lipid must
protrude 1.5 nm from the lipid bilayer up into the active site of sPLA2 adsorbed to the membrane
surface (Berg et al., 2001). Normally the frequency of such phospholipid protrusions is very low
because of the “friction” opposing this movement created by favorable interactions between
neighboring fatty acid tails. Hence, healthy cells show minimal susceptibility to hydrolysis by
sPLA2. A reduction of these associations between carbon chains, and thus a decrease in that
“friction,” will increase the likelihood of a single lipid migrating from the membrane to be
cleaved. Here we assume that this reduction in lipid interactions is analogous to the phase
transition of artificial membranes, which is known to greatly enhance sPLA2 activity (Bell et al.,
1995; Bell and Biltonen, 1989; Honger et al., 1996; Lichtenberg et al., 1986; Menashe et al.,
1981). Therefore, data from vesicles were used to estimate the magnitude of energy reduction
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between neighboring lipids during apoptosis and the consequential change in the density of lipid
protrusions. Patman GP and TMA-DPH anisotropy were measured across the main phase
transition of vesicles (pure DMPC, DPPC, or DSPC) to obtain the total change in anisotropy or
GP in each system. The average change in enthalpy for these phase transitions was used to
determine a coefficient relating TMA-DPH and Patman measurements to energy changes (Table
1). Linear regression of the enthalpy and probe fluorescence in Table 1 yielded coefficients of
3.00 × 10–6 TMA-DPH anisotropy units/J and 1.12 × 10–5 Patman GP units/J. These coefficients
were then applied to the change in TMA-DPH anisotropy and Patman GP after about 3 h of TG
treatment (Figs. 5-4C and 5-6B), the time at which the alive and susceptible subpopulation was
the largest (Fig. 5-2B). As shown in Table 2, TMA-DPH and Patman measurements predicted a
–1.31 × 10–20 J and –1.11 × 10–20 J change in interaction energy per phospholipid after TG
treatment respectively. The change in density of lipid protrusions after TG treatment was
calculated from an adaptation of the theory presented by Mouritsen and co-workers (Halperin
and Mouritsen, 2005; Hoyrup et al., 2004).

  yz 

p( z )  p( 0) exp
k
T
 B 

Eq. 6

where p(z) is the probability or frequency of protrusions of distance z and y is the energy cost of a
protrusion of distance z. Some of the parameters, p(z), p(0) and y, are not known for a cell
membrane. However, the proportional change in protrusion frequency (Δp(z)) upon discounting
the energy cost due to reduced lipid-lipid interactions can be calculated without explicit
knowledge of the basal condition as follows:
Eq. 7
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where Δyapp is the apparent change in interaction energy estimated from the TMA-DPH or
Patman data and z = 1.5 nm. As indicated in Table 2, TMA-DPH and Patman predicted a 50–
100-fold increase in the protrusion frequency after 3 h treatment with TG. We note that this
analysis assumes that the membrane environments detected by these probes are generally
synonymous with those hydrolyzed by sPLA2. The diversity of structure within cell membranes
surely implies that the numbers calculated here are averages for the overall system. Our
calculations also assume that all of the phospholipids “seen” by TMA-DPH and Patman have
experienced similar physical alterations. If this assumption is not true, then a smaller proportion
of lipids is experiencing a greater change in protrusion probability than we have estimated here.
One of the challenges of detailed biophysical studies on simple artificial membranes is
applying the results and conclusions to complex biological systems. In this paper, we have
demonstrated a combined application involving a membrane-binding enzyme (sPLA2) and two
fluorescent membrane probes. In one case, the supporting work with artificial bilayers included
thermodynamic analysis relating kinetic and structural data for sPLA2 to create a molecular
model relating lipid dynamics (protrusion fluctuations) to enzyme activity (Halperin and
Mouritsen, 2005; Hoyrup et al., 2004). In the other, we assessed the behavior of TMA-DPH and
Patman with artificial membranes quantitatively to provide a frame of reference for interpretation
of data with cells (Table 1 and Ref. (Franchino et al., 2013)). These quantitative approaches were
then used together here to interpret biological phenomena at a level of detail greater than
generally achieved in the discipline of cell membrane biology. In particular, this study
demonstrates a new level of real time application of fluorescence spectroscopy to bulk samples
of living cells.
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Table 1: Changes in TMA-DPH anisotropy and Patman GP during main phase transitions of
DMPC, DPPC, or DSPC vesicles.
Tm (°C)a

ΔH (joules)a

ΔTMA-DPH rb

ΔPatman
GPc
23.7
2.43E+04
−0.0943
−0.43
DMPC
41.4
3.46E+04
−0.0916
−0.44
DPPC
54.4
4.18E+04
−0.1235
−0.51
DSPC
a Obtained from averages of all relevant observations reported in LIPIDAT (Koynova and
Caffrey, 1993).
b Assessed using Eq. 3 as described in Materials and Methods.
c Obtained by applying Eq. 3 to Patman spectral data as a function of temperature from Ref.
(Franchino et al., 2013).
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Table 2: Change in frequency of lipid protrusions during TG-induced apoptosis.

TMA-DPH
Patman

Δr or ΔGP

Δyapp (joules)

fold-increase in p(z)

−0.0237
−0.0931

−1.31E-20
−1.11E-20

99.2
48.9

a

The changes in TMA-DPH anisotropy and Patman GP after 3.25 h TG treatment (the time at which the
subpopulation of alive and susceptible cells is at a maximum) are from Figs. 5-4C and 5-6B respectively.
b
The coefficients calculated from Table 1 were used to determine Δyapp, the apparent change in
interaction energy estimated from the TMA-DPH or Patman data
c
Calculated according to Eq. 7.
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Figure 5-1: Timing of apoptotic events during TG-induced death.
Cells were treated in culture with either DMSO (vehicle control; open symbols) or TG (solid symbols) for
various times as indicated on the x-axis. Caspase activation (triangles, n = 6–13 in TG groups, 47 in
control group), PS externalization (circles, each time point is a separate experiment), and DNA
degradation (squares, each time point is a separate experiment) were assessed via flow cytometry after
incubation with FAM-VAD-fmk (30 min), AlexaFluor-labeled Annexin-V (15 min), or propidium iodide
with Triton X-100 (10 min) respectively. Death (inverted triangles, n = 1–31 in TG groups, 72 in control
group) was determined by cell permeability to trypan blue. Data are represented as the percentage of the
population positive for each response. Nonspecific binding of FAM-VAD-fmk (Pozarowski et al., 2003)
was subtracted from all time points.
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Figure 5-2: Susceptibility of TG-treated cells to sPLA2.
Cells were treated for various times with DMSO (vehicle control; open squares) or TG
(solid squares) in cell culture. (A) Fatty acid release was measured using ADIFAB. The
total amount of hydrolysis was calculated as the maximal change in ADIFAB GP after
addition of sPLA2 (n = 1–6 in TG groups, 20 in control group). (B) The percentage of the
cell population that was both alive and susceptible to sPLA2 was assessed using
propidium iodide (n = 1–18 in TG groups, 63 in control group) as described in Materials
and Methods. (C) Cells were incubated with Z-VAD-fmk or control solvent (DMSO) for
30 min before TG or DMSO treatment. The percentage of cells alive and susceptible to
hydrolysis by sPLA2 was assayed as in Panel B. Groups differed significantly by one-way
analysis of variance (p < 0.0001, n = 4–8 per group). A post-test (Bonferroni)
demonstrated that the TG group differed from all others (p < 0.01) and that cells treated
with Z-VAD-fmk alone or before TG were indistinguishable from control cells.
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Figure 5-3: Effect of TG treatment on MC540 fluorescence.
The effect of DMSO (open squares) or TG (solid squares) on MC540 emission intensity (A)
or spectral maximum (B, expressed as shift compared to that induced by ionomycin) was
obtained and calculated as explained in Materials and Methods (n = 1–13 in TG groups, 45 in
control group). (C) Cells were pretreated with Z-VAD-fmk or control solvent (DMSO),
equilibrated with MC540, and analyzed by flow cytometry. Data represent the percentage of
the cell population staining positive for MC540. Groups differed significantly by one-way
analysis of variance (p < 0.0001, n = 5 per group). A Bonferroni post-test revealed that TG
significantly increased MC540 fluorescence (p < 0.001). Treatment with Z-VAD-fmk alone
was not distinguishable from control cells (p > 0.05). Addition of Z-VAD-fmk before TG
treatment was significantly different from both control cells and cells incubated with TG alone
(p < 0.05 in both cases).
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Figure 5-4: DPH and TMA-DPH anisotropy and localization in TG-treated cells.
After incubation with DMSO (open squares) or TG (solid squares) for the indicated times, DPH (A and
B) or TMA-DPH (C and D) was added to cell samples. Panels A and C show anisotropy measurements
(DPH: n = 2–5 in TG groups, 26 in control group; TMA-DPH: n = 2–6 in TG groups, 30 in control
group). Panels B and D are representative two-photon images showing localization of probe intensity
after 2 h TG treatment and 12 min equilibration with the probe. Fluorescence intensity is represented by a
relative false color scale (blue, low; red, high).
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Figure 5-5: Effect of TG incubation on Laurdan intensity and GP.
(A) Laurdan GP of cells treated with DMSO (open squares) or TG (solid squares) for various times was
assessed via fluorescence spectroscopy (n = 1–8 in TG groups, 31 in control group). Values of GP were
calculated from the intensities measured 600 s after probe addition. (B) Laurdan intensity was visualized
by two-photon microscopy after a 3 h incubation with TG and 12 min with probe. Fluorescence intensity
is represented by a relative false color scale (blue, low; red, high). (C) Images such as that in Panel D
were quantified (n = 151 cells) by calculating the difference in GP between pixels corresponding to the
cell perimeter and those in the middle (see Materials and Methods) for control (open squares) and TGtreated cells (solid squares). (D) The image from Panel B is shown with false coloring representing
Laurdan GP (blue = –0.25 GP units; red = 0.75 GP units).
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Figure 5-6: Patman localization and GP after TG treatment.
(A) Patman intensity was visualized by two-photon excitation microscopy after 3 h TG treatment plus 12
min with probe. Fluorescence intensity is represented by a relative false color scale (blue, low; red, high).
(B) Patman GP of cell samples treated with DMSO (open square) or TG (solid squares) was assessed by
fluorescence spectroscopy. GP was assessed 400 s after probe addition (n = 2–7 in TG groups, 24 in
control group).
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Figure 5-7: Effect of TG on Patman equilibration kinetics.
(A) Patman was added to control cells and intensity measured for 400 s. Normalized intensity at both 435
nm (solid curves) and 500 nm (dashed curves) is shown to illustrate differences in equilibration kinetics.
(B, C, and D) Equilibration time profiles of intensity at 435 nm, intensity at 500 nm, and GP (dotted
curves) from control samples (B), samples treated with TG from 2–5 h (C), and samples treated for over
6.5 h (D). Data from both wavelengths were normalized to that measured at 435 nm at 400 s and
aggregated (n = 10–25 per group). Gray shading represents ± SE.

72

Figure 5-8: Effect of TG on membrane properties and Patman distribution.
(A) The effect of TG on the fraction of the probe in the “slow” environment (circles), the polarity of
“slow” environment (inverted triangles), and the polarity of the “fast” environment (triangles) were
estimated using the model developed in (Franchino et al., 2013). (B) The same model was used to
estimate the change in the equilibrations rates of the “slow” environment (squares) and the “fast”
environment (diamonds). Model parameters and error estimates were obtained from nonlinear regressions
of the data shown in Figs. 7 B and C as explained in Materials and Methods.
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CHAPTER 6: IONOMYCIN CAUSES SUSCEPTIBILITY TO PHOSPHOLIPASE A2 WHILE
TEMPERATURE-INDUCED INCREASES IN MEMBRANE FLUIDITY FAIL:
POSSIBLE INVOLVEMENT OF ACTIN FRAGMENTATION

Introduction
Prior studies have investigated the role of biophysical alterations to the plasma membrane
in its susceptibility to hydrolysis by sPLA2. Fluorescent membrane probes such as MC540,
Laurdan, DPH, TMA-DPH, and Patman have been used to detect increases in lipid spacing and
fluidity that correlate with susceptibility (Bailey et al., 2009; Bailey et al., 2007; Best et al.,
2002; Harris et al., 2001; Heiner et al., 2008). These biophysical alterations (as seen by MC540)
preceded all other membrane changes during DEX-induced apoptosis in S49 cells (Bailey et al.,
2009), so it is clearly important in availability of cell membranes to act as a substrate for the
enzyme. However, other cases have been reported in which membrane fluidity is altered and
does not result in hydrolysis by sPLA2 such as vesicles of different compositions experiencing
phase transitions (Bell et al., 1996).
This chapter attempts to more fully define biophysical changes in the plasma membrane
that are directly responsible for susceptibility to hydrolytic attack by comparing temperature- and
ionomycin-induced alterations of the plasma membrane. These two treatments result in similar
changes in membrane fluidity as currently defined, yet have different impacts on membrane
vulnerability to attack. In this study, susceptibility induced by ionomycin is used because of its
fast-acting and synchronous effect on cell samples. The membrane probe Patman is used to
define the difference between the membrane alterations caused by these two treatments.
Actin fragmentation is proposed as a possible mechanism for the extra alteration caused
by ionomycin. This hypothesis is plausible because actin and actin-associated proteins are known
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to be cleaved/altered during apoptosis (Franklin-Tong and Gourlay, 2008; Gourlay and
Ayscough, 2005; Leadsham et al., 2010; Wang, 2000). Additionally, various studies have
reported changes in membrane fluidity (assayed with fluorescent membrane probes) in
conditions that involve cytoskeleton alterations. Examples include disorders of abnormal cell
locomotion (Fiorini et al., 2000), T-cell activation (Gaus et al., 2005; Rajendran et al., 2009),
detachment of cells from focal adhesion proteins (Gaus et al., 2006), membrane receptor
clustering (Pato et al., 2008), diabetic nephropathy (Jones et al., 1998), and endocytosis (Wolkers
et al., 2003). Magnetic field exposure (Santoro et al., 1997), hydrogen peroxide treatment (Zhu et
al., 2005), and cytoskeleton-disrupting drugs (Huotari et al., 1996) also cause alterations in
membrane order that correlate with changes in the cytoskeleton.

Results
Temperature-induced changes in membrane fluidity were assessed with the membrane
probe TMA-DPH. Cells were incubated at temperatures ranging from 32 – 45 °C with and
without ionomycin. As shown in Fig. 6-1, TMA-DPH anisotropy decreased as temperature was
increased (black bars), and ionomycin caused an additional drop in anisotropy at all temperatures
(striped bars). A two-way analysis of variance indicated that ionophore treatment was
responsible for 30.98% of the variation within the data (p<0.0001), temperature caused 23.81%
of the variation (p<0.0001), and the interaction between the two was insignificant (3.35% of total
variation; p=0.0918). The TMA-DPH anisotropy of control cells at 45 °C was comparable to
that of ionomycin-treated cells at 32 °C.
The solvation relaxation-sensitive probe Patman was also used to determine if altering
temperature could induce biophysical membrane changes sufficient to mimic apoptotic systems.
Again, S49 cells were incubated with Patman at a range of temperatures and the GP was
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calculated. Linear regression of samples from 32 – 45 °C revealed a slope of −0.009249 ±
0.003064 (p=0.0046), suggesting a −0.12026 GP unit drop across this temperature range. This
result is comparable to data the −0.11533 Patman GP unit decrease during TG-induced apoptosis
reported in Chapter 5.
Because ionomycin-treated cells at 32 °C and control cells at 45 °C had similar TMADPH anisotropies, the amount of hydrolysis resulting after incubating these samples with sPLA2
was assayed using ADIFAB. Figure 6-2 shows example profiles of ADIFAB GP over time, with
an increase suggesting fatty acid release from the plasma membrane. Regardless of temperature,
there was a small rise in GP after addition of sPLA2 (first dotted line) with a subsequent return to
baseline levels as the product is re-acylated into the membrane as is characteristic of control cells
(Wilson et al., 1999). Ionomycin was added at the second dotted line in the 32 °C sample (black
curve), causing a large increase in ADIFAB GP, suggesting the ionophore rendered the cells
susceptible to attack by sPLA2. Incubating the sample at 45 °C (red curve) caused no such
vulnerability to hydrolysis by the enzyme.
It is known that calcium influx causes externalization of PS on the cell surface (Bevers et
al., 1983; Nielson et al., 2000; Zhou et al., 1997), so the effect of temperature on annexin V
binding was measured via flow cytometry. As shown in Fig. 6-3, cells at 32, 37, and 45 °C
exhibit low levels of PS on the cell surface (24.7, 18.6, and 34.7% of the cell population staining
positive, respectively). The effect of temperature was not statistically significant by one-way
analysis of variance (p = 0.5878, n = 3), and Bonferroni’s multiple comparison post test showed
that none of the pairs of columns were significantly different from each other (p > 0.05 in all
cases).
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To test whether larger amounts of externalized PS would cause the kind of susceptibility
seen with ionomycin treatment, PS was added exogenously to the outer leaflet of the plasma
membrane. This was accomplished by incubating cells with vesicles composed of 50% egg PC
and 50% brain PS as described in Materials and Methods. Successful delivery was assessed by
fluorescent annexin V binding, measured by flow cytometry. Fig. 6-4a shows an example set of
histograms of PS exposure of control cells (black) and cells incubated with vesicles containing
PS (green). Samples were fit by nonlinear regression (sum of Gaussian curves) to quantify the
number of cells staining low, medium, or high levels of intensity as described in the figure
legend. As summarized in Fig. 6-4b, incubating the cells with exogenous PS most obviously
increased the fraction of cells staining at a medium intensity (p < 0.001, two-way analysis of
variance with Bonferroni’s post test, n = 7).
After incubation with these vesicles, samples were assayed for susceptibility to sPLA2 by
repeating the experiments of Fig. 6-2. Fig. 6-4c shows example time profiles of ADIFAB GP in
cells at 37 °C after addition of the hydrolytic enzyme. There appeared to be no difference
between control cells and cells loaded with PS. The maximum rise in GP was quantified for
multiple replicates of these experiments at both 37 and 45 °C and is summarized in Fig.6- 4d.
These data suggest a slight increase in fatty acid release from these samples both as temperature
increases and PS is added, but neither of these effects (nor an interaction between the two) was
significant as shown by a two-way analysis of variance (p = 0.25, 0.59, and 0.92, respectively).
Because Patman equilibration has been used to detect biophysical membrane changes that
are indistinguishable by TMA-DPH or Patman GP alone, those kinetics were examined here. As
before, intensity at both 435 and 500 nm was collected over time for 500 s after Patman was
added to cell samples. These data were fit by nonlinear regression by an arbitrary function
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analogous to Eq. 5 and normalized to the maximum intensity at 435 nm. These normalized data
were then aggregated with others collected at the same temperature. Figure 6-5a is an example of
this at 37 °C with error bars representing the SE. These aggregated curves were then fit by
nonlinear regression (Eq. 5) and analyzed according to the model proposed and utilized
previously (Franchino et al., 2013). In this way, it is possible to determine the fraction of Patman
located in two different configurations in the membrane, the polarity of those configurations, and
the rate at which the probe equilibrates with its environment in those two configurations. The
temperature-dependence of all of these parameters was determined by linear regression. None
correlated significantly with temperature except the polarity of the more slowly-equilibrating
configuration (p=0.0001), which is shown in Fig. 6-5b. This configuration became more polar as
temperature increased.
Ionomycin’s effect on Patman equilibration was examined in a slightly different way
because the ionophore acts quickly and on the entire population simultaneously. Computer
simulations were performed to determine what the expected the curves would look like if certain
parameters were altered by ionomycin addition midway through Patman’s equilibration with the
membrane. Figure 6-6a shows an expected intensity profile if the distribution of the probe among
the two configurations was altered. The intensity at both wavelengths immediately increased and
to different degrees. When only the polarity of one of the configurations was changed by
ionomycin, a curve like that seen in Fig. 6-6b resulted, with the intensity at 435 and 500 nm
changing in opposite directions but with the identical magnitude. If both the distribution of the
probe and the polarity of its environment were altered after ionophore treatment, it was possible
to get a curve such as that shown in Fig. 6-6c. In this case, the intensity at the two wavelengths
changed trajectory in opposite directions and with uneven scalar values.
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In order to quantify the actual effect of ionomycin, the intensity profiles were fit as
described in Materials and Methods (example: Fig. 6-6d). In this way it was possible to obtain
the amount (both magnitude and direction) and rate at which ionomycin altered the trajectory of
the equilibration. The scalar values of the 435 and 500 nm curves (normalized to the total
intensity at 435 nm) were summed to determine if they were mirror images of each other, or in
other words, if that sum were equal to 0. The average sum of ionomycin at all temperatures was
actually 0.2256 and significantly different from 0 (p<0.0001). This suggests that ionomycin
treatment causes a change in probe distribution as well as the polarity of the probe’s
environment, a different result than that seen with temperature manipulation.
To investigate the possibility that ionomycin causes cytoskeletal alterations while
temperature does not, F-actin was stained with fluorescent phalloidin and photographed via
confocal microscopy. Fig. 6-7 shows example images of control cells, ionomycin-treated cells,
and cells incubated at 45 °C (Panels A, B, and C, respectively). Control cells (Fig. 6-7A)
contained more fibrous actin filaments while Fig. 6-7B shows smaller actin fragments after
ionomycin treatment as if the fibers had been severed. Cells incubated at 45 °C for 10 min (Fig.
6-7C) appeared more fibrous than ionomycin-treated cells, but not quite like the corresponding
controls. In order to quantify this effect, ImageJ software was used to calculate the circularity
index of all particles in such images as explained in Materials and Methods. Figure 6-8 shows
the average percentage of particles with the highest circularity index (0.75 – 1) of images of both
control and ionomycin-treated cells at 32, 37, and 45 °C. Control cells at 45 °C contained more
circular (and therefore shorter) actin filaments than those incubated at lower temperatures, but
ionomycin treatment caused an increase in the percentage of particles of high circularity at every
temperature. Two-way analysis of variance reported that ionomycin treatment was the main
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source of variation (40.14%, p<0.001) with temperature contributing to 14.29% of the variation
(p=0.0315) without significant interaction between the two (p=0.2751).
To further investigate the connection between actin severing and susceptibility to sPLA2,
changes in the actin cytoskeleton were investigated during TG-induced apoptosis. As shown in
Fig. 6-9, 4 h TG treatment (Panel A) caused actin fragmentation compared to control cells (Panel
B). Images of cells treated with TG for 1 – 4 h and corresponding vehicle controls were analyzed
as described for Fig. 6-8 and the percentage of pixels of the highest circularity is summarized in
Fig. 6-9C. The overlaid curve (from Fig. 5-2) is included to show the temporal correlation
between actin alterations and susceptibility of TG-treated cells to sPLA2. The data are fit by
nonlinear regression (a sigmoid function) to estimate the time at which each effect has reached
50% of its maximum. The inflection point of actin fragmentation occurs at 1.256 h (95%
confidence interval: 0.3351 – 2.177 h) while that of susceptibility does not occur until 2.006 h
(95% confidence interval: 1.783 – 2.229 h).

Discussion
S49 cells were incubated at various temperatures in order to manipulate phospholipid
fluidity independently of other common alterations to the plasma membrane that occur during
calcium loading or apoptosis. The membrane probes Patman and TMA-DPH were used to
determine if altering temperature could induce changes of sufficient magnitude to match those
observed in previous studies. Heating the cells to 45 °C increased the fluidity of the membrane,
allowing greater probe rotation within the bilayer (hence a decrease in TMA-DPH anisotropy), to
the same degree that ionomycin treatment did at 32 °C (Fig. 6-1); however, increasing the
temperature to 45 °C failed to induce susceptibility of the lipids to hydrolysis by sPLA2 (Fig. 62). This clearly implies that the absolute value of TMA-DPH anisotropy in a membrane cannot
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fully predict the availability of substrate for the enzyme. Because the anisotropy always drops
further when ionomycin is added (Fig. 6-1), it appears TMA-DPH is picking up an additional
alteration occurring in the membrane after calcium loading, but it cannot give us enough
information to understand that change.
A simple cause of this supplementary change detected by TMA-DPH could involve the
exposure of the negatively-charge PS to the outer leaflet of the plasma membrane, a wellunderstood change known to correlate with membrane vulnerability to hydrolytic attack (Bailey
et al., 2009; Nielson et al., 2000). As demonstrated in Fig. 6-3, increasing the incubation
temperature to 45 °C did not produce a statistically significant increase in the population of cells
staining annexin V positive. While nearly a third of the cell population exhibited PS exposure,
this was not comparable to ionomycin treatment, which causes nearly 100% of a cell population
to flip PS to the outer leaflet (Nielson et al., 2000). If a negatively-charged outer leaflet fully
accounts for the difference between the susceptibility of the two samples in Fig. 6-2, it would be
probable that increasing the amount of PS on the surface would render the cells vulnerable to
sPLA2. Figure 6-4b illustrates that loading the outer leaflet with exogenous PS was successful,
yet this did not cause a significant increase in susceptibility (Fig. 6-4D). It could be argued that
susceptibility was not affected because the bulk of the annexin V positive cells in Fig. 6-4A and
B stained with lower intensity than seen in ionomycin-treated samples (largely staining at the
“high” intensity). To investigate this possibility, parallel annexin V and susceptibility assays
were compared to determine if the percentage of cells with “high” intensity staining correlated
with the amount of fatty acid release from the membrane. Linear regression revealed that there
was no significant correlation between ADIFAB GP increase and cells with “high” intensity
annexin V staining in control cells or cells loaded with exogenous PS (p = 0.2793 and 0.3357
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respectively). By manipulating exposure of PS and membrane fluidity independent of cell death,
it was possible to investigate their individual roles in membrane susceptibility to hydrolysis. As
demonstrated in Figs. 6-1 – 6- 4, both extensive PS exposure in the outer leaflet and temperatureinduced increases in membrane fluidity (or even a combination of the two) were insufficient to
cause S49 cells to become susceptible to hydrolysis by sPLA2.
As published previously, the equilibration of Patman with the membrane can reveal more
information about the biophysical properties of the phospholipid bilayer than its GP alone by
applying a model in which Patman can exist in two different configurations in the membrane
(Franchino et al., 2013). By examining time profiles of both 435 and 500 nm emission intensities
after Patman addition, the polarity of these configurations, rates of equilibration of these two
configurations, and proportion of probe in each configuration can be determined (Franchino et
al., 2013). Aggregated intensity profiles at different temperatures were fit as explained in
Materials and Methods (Fig. 6-5A). The abovementioned model was applied to the resulting
nonlinear regression parameters and revealed that altering temperature only had a significant
effect on the polarity of the “slow” configuration (Fig. 6-5B). The distribution of probe was
unchanged (linear regression: p=0.219). During TG-induced apoptosis, the polarity of the
membrane was similarly altered (intuitive because of the change in Patman GP) but the largest
change was in the distribution of the probe. Patman molecules shifted from residing primarily in
the “slow” configuration into the “fast” configuration. This was interpreted to indicate a decrease
in interlipid interactions that would anchor probe (and other lipid molecules) deep in the
membrane making it easier for an individual molecule to protrude from the membrane . Because
this parameter was unchanged with temperature manipulations, a condition in which
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susceptibility is not induced, this redistribution of probe could be an important characteristic of
the additional alteration caused by ionomycin.
To identify whether ionophore treatment significantly alters the distribution of Patman
between configurations, and thus the anchoring of lipid molecules to the membrane, ionomycin
was added midway through the probe’s equilibration as shown in Fig. 6-6D. The addition of this
drug caused a deviation from the original trajectory of Patman’s emission intensity as it
equilibrated with the membrane. As this makes determining exact, quantifiable changes in the
above parameters difficult to obtain, a more qualitative approach was taken. This deviation was
quantified by nonlinear regression as described in Materials and Methods to reveal a rate
(constrained to be identical between 435 and 500 nm) and a scalar value for each wavelength.
Computer simulations were performed to determine what these scalar values would be if
different parameter values (polarity of the “slow” or “fast” configurations versus the distribution
of probe among them) were altered. If only membrane polarity was changed (as it is when only
temperature is varied), the scalars were always of opposite signs and equal magnitudes (Fig. 66B). Any other result only arose if the distribution of probe among configurations was altered
(Fig. 6-6A and C). Therefore, if the sum of the normalized scalar values from 435 and 500 nm
intensity profiles was always equal to zero, that would suggest a change in membrane polarity
only. However, as reported in the Results section, the actual sum was a number significantly
different from zero, which implicates that a redistribution of probe was caused by ionomycin
treatment. Just as with TG-induced apoptosis , this suggests that calcium loading causes a
reduction in the anchoring forces restricting phospholipids from migrating into the active site of
sPLA2, an effect absent when only temperature is varied.
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To summarize to this point, ionomycin caused an additional alteration in membrane
fluidity beyond that seen with increased temperature that was undetectable by absolute TMADPH anisotropy or Patman GP values. Patman equilibration kinetics analyses suggested that
ionophore treatment reduces the anchoring of molecules deep in the membrane while
temperature variation only alters the amount of water in the membrane. Because removal of actin
filaments has been to shown to cause membrane softening (Lorenz et al., 2009), alterations in the
actin cytoskeleton were investigated as a possible source of this discrepancy. A particle analysis
of confocal images revealed that actin filaments are shorter (higher circularity index) after
ionomycin treatment (Figs. 6-7 and 6-8), suggesting the network has been disrupted by some
severing mechanism. While heating cells to 45 ºC increased the percentage of pixels in particles
of higher circularity as well, the effect contributed less to the total variation than ionomycin and
was less significant. The actin fragmentation at the high temperatures could also be due to the
cells beginning to experience heat shock and initiate apoptotic cascades. Despite this small
effect, ionomycin disrupts the actin network to a greater degree which would have a larger effect
on membrane softness.
If actin disruption is the cause of weakened interactions among lipids leading to a
redistribution of Patman after ionomycin treatment, the same should be true during TG-induced
apoptosis. The experiments and analyses of Figs. 6-7 and 6-8 were repeated after varying lengths
of incubations with TG. At a time of maximal membrane susceptibility to sPLA2 (4 h with the
drug), actin was severed compared to control samples. The percentage of pixels in particles of
highest circularity was not as high as ionomycin images, presumably because ionomycin affects
the entire population in a more synchronized manner than TG. Ionophore treatment induces
100% of the cell population into an “alive, yet susceptible” state (Bailey et al., 2007) while the
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corresponding population in TG-induced apoptosis reaches a maximum just above 30% of the
population .
Finally, the temporal onset of susceptibility to sPLA2 during TG-induced apoptosis was
overlaid with the onset of actin fragmentation for comparison (Fig. 6-9C). Although the 95%
confidence intervals overlap, the data suggest that actin severing precedes or correlates with
membrane alterations that cause cells to become vulnerable to cleavage. Future studies will use
actin-severing drugs to isolate this effect and further validate the hypothesis that disruption of
actin networks must occur for full susceptibility of plasma membranes to hydrolysis by sPLA2.
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Figure 6-1: Effect of temperature and ionomycin on TMA-DPH anisotropy.
Cells were equilibrated at indicated temperature for 10 min before measurements made with TMA-DPH
as described in Materials and Methods (before ionomycin; black bars). Ionomycin was then added and an
additional measurement made after another 10 min (after ionomycin; striped bars). Two way analysis of
variance showed that both ionomycin treatment and temperature were significant sources of variation
(30.98%,p<0.0001 and 23.81%, p<0.0001 respectively) with interaction contributing to 3.35% of the total
variation (p=0.0918) with n=9 – 12.
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Figure 6-2: Example time profiles of ADIFAB GP after sPLA2 addition at 32 and 45 °C.
Cells were incubated at either 32°C (black curve) or 45 °C (red curve) for 5 min prior to data acquisition.
ADIFAB was added at t=0 with sPLA2 and ionomycin (only for the 32 °C sample) added at the dotted
lines as indicated. Emission intensity was collected at 432 and 505 nm and the GP calculated as
described in Materials and Methods.
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Figure 6-3: Annexin V binding at different temperatures assayed
by flow cytometry.
Cells were incubated at indicated temperatures for 10 min prior to
staining with fluorescent annexin V according to the manufacturer’s
protocol and as described in Materials and Methods. Resulting
histograms of annexin V intensity were fit by nonlinear regression with
a function composed of three Gaussian curves (low, medium, and high
annexin V intensity). The means were constrained to be shared among
the three temperatures for each experiment with the low population
constrained to be centered at zero. The data are represented as the sum
of the fraction of cells in the medium and high intensity populations.
One way analysis of variance showed the means are not significantly
different (p = 0.5878, n = 3). Bonferroni post test comparing all
columns showed that none of the temperatures could be distinguished
from each other (p > 0.05 in all cases).

88

Figure 6-4: Susceptibility of cells loaded with exogenous PS.
Cells were incubated with vesicles containing exogenous PS for 30 min as described in Materials and
Methods. Control cells are shown in black, cells with added PS in green. Panel A: Flow cytometry
histograms of annexin V staining. Histograms were fit by nonlinear regression with a function composed
of four Gaussian curves (low, medium, and high annexin V intensity as indicated with two Gaussian
curves summed for the high population). The means were constrained to be shared among the control
sample and the sample with added PS for each experiment. The percent of the cell population in each
category was calculated using the area in each Gaussian curve. Panel B: Experiments were analyzed as
shown in Panel A and the average percent of the cell population staining medium or high intensity are
summarized here (n = 7). Two-way analysis of variance shows that the addition of vesicles contributed to
23.57% of the variation (p = 0.0001). Bonferroni’s post test reported that loading the cells with PS
statistically increased staining in the medium population (p < 0.001) but not the high intensity population
(p > 0.05). Panel C: Example time profiles of ADIFAB GP (see Materials and Methods) with sPLA2
added at the dotted line. Panel D: The maximum rise in ADIFAB GP of experiments such as those in
Panel C was quantified and is summarized here (n = 3–9). Two-way analysis of variance reported that
means are not statistically different (effect of temperature: p = 0.2549; effect of added PS: p = 0.5940;
and interaction: p = 0.9226).
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Figure 6-5: Patman equilibration analysis at different temperatures.
Patman emission was gathered at 435 and 500 nm over time after 10 min equilibration at indicated
temperature as described in Materials and Methods. Experiments at the same temperature were
aggregated by normalizing each set to the maximum intensity at 435 nm. Panel A is an example aggregate
at 37 °C. These aggregates were fit by nonlinear regression and input into model equations as described
in Materials and Methods. None of the model parameters correlated significantly with temperature except
for the polarity of the slow configuration (Panel B; n = 6 – 26; p = 0.0001).
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Figure 6-6: Effect of ionomycin on Patman equilibration based on computer simulations and
experiments.
Panels A – C are example time courses from computer simulations in which ionomycin was added
midway through Patman’s equilibration. Panel A: Example simulation if ionomycin only alters the
distribution of probe in the two configurations. Panel B: Example simulation if ionomycin only alters the
polarity of one of the configurations. Panel C: Example simulation if both the distribution of the probe
and the polarity of the environment are altered with ionomycin treatment. Panel D: An example of an
actual time profile of Patman intensity. Data are fit by nonlinear regression as described in Materials and
Methods.
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Figure 6-7: F-actin of control cells, ionomycin-treated cells, and cells incubated at 45 °C for 10 min
visualized by phalloidin staining.
Cells were harvested and treated for 10 min (Panel A: control vehicle, Panel B: ionomycin, Panel C: 45
°C) before being mounted onto slides. They were then simultaneously fixed, permeablized, and stained
with fluorescent phalloidin as described in Materials and Methods. These images were collected via
confocal microscopy using a 60x objective with a 3x digital zoom.
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Figure 6-8: Effect of temperature and ionomycin on F-actin particle circularity.
Images such as those in Fig. 7 were analyzed using ImageJ as described in Materials and Methods. Cells
were incubated for 10 min at the indicated temperature before simultaneous fixation, permeablization, and
staining (black bars). Some samples were incubated for 10 min at temperature and then 10 more with
ionomycin (red bars). Data are presented as the percentage of pixels in the image that are part of a particle
of circularity index between 0.75 – 1.Two way analysis of varianceshowed that both temperature and
ionomycin treatment were significant sources of variation (p = 0.0315 and p <0.0001 respectively) with
temperature comtributing to 14.29% of the total variation and ionomycin to 40.14%. The interaction
between the two was insignificant.
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Figure 6-9: Actin fragmentation during TG-induced apoptosis.
Panels A and B are confocal images of phalloiding-stained F-actin after 4 h TG treatment (A) or 4 h
control vehicle (B). Slides were prepared as in Fig. 7 and as described in Materials and Methods. Images
were analyzed as in Fig. 8 and the percentage of pixels in particles of highest circularity (0.75 – 1) are
plotted in Panel C (black curve). The red curve overlaid in Panel C is the total change in ADIFAB GP
after addition of sPLA2 after different incubation times with TG (data from chapter 3).
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CHAPTER 7: SUMMARY
Secretory PLA2 has been an interesting topic in biophysical studies of membranes
because it acts at a lipid-water interface and is regulated by the state of its substrate. The protein
itself always exists in an active state, but not all bilayers are equally susceptible to hydrolytic
attack. Furthermore, different isoforms of the enzyme exhibit differing levels of activity toward
the same membranes. Originally, it was thought that negative charge on the membrane surface
was the key factor in determining susceptibility of the bilayer to the enzyme’s activity. More
recently, this lab and others have emphasized the importance of the biophysical state of the
membrane. In this dissertation, the molecular details of these physical properties were
investigated.
Prior to this study, it was known that the plasma membrane undergoes changes in
apoptosis detected by MC540, Laurdan, and DPH. An early increase in MC540 fluorescence
indicates a decrease in lipid packing. This effect occurs in ionomycin-, DEX-, and TG-induced
apoptosis, yet different isoforms respond differently to these treatments. Here it was found that a
large enough increase in lipid packing caused increased membrane permeability to propidium
iodide. Ionomycin treatment did not cause this increase in membrane permeability, and only the
snake venom and hGX enzymes were able to attack these cells. Apoptotic cells, on the other
hand, showed both the MC540 effect and the intermediate propidium iodide staining. These cells
were attacked by the hGIIa and hGV isoforms. Understanding this physical change better,
therefore, can explain some of the specificity of different human isozymes.
Lipid peroxidation was hypothesized as a possible mechanism for this increase in
membrane permeability. This was tested by assaying membrane oxidation during apoptosis. The
timing of reactive oxygen species appearing in the membrane correlated temporally with hGIIa
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activity. Cells were then treated directly with oxidizing agents, resulting in fatty acid release after
incubation with hGIIa sPLA2.
Previous studies assaying Laurdan GP and DPH anisotropy during apoptosis suggested
possible changes in membrane order and fluidity, but these were not always temporally
associated with susceptibility. Here, charged analogs of these probes (Patman and TMA-DPH)
were utilized to more confidently assay the plasma membrane rather than having data
interpretation complicated by internal membrane staining. These studies revealed changes in
membrane order and fluidity that matched the onset of membrane vulnerability to hydrolytic
attack. These results combined with Patman equilibration results revealed that TG treatment
caused enhanced phospholipid mobility, an increase in membrane polarity (mostly affecting
deeper portions of the membrane), and a decrease in the forces that anchor lipids to the center of
the bilayer. Using parallel vesicle studies with these same probes, the change in these forces was
quantified in terms of energy and used to predict a 50–100 fold increase in the density of lipid
protrusions into the active site of sPLA2.
Next this physical change to the membrane and the effect of PS exposure were isolated to
discover their individual influence on membrane susceptibility. Manipulating temperature caused
alterations detected by Patman and TMA-DPH of sufficient magnitude to mimic ionomycin
treatment, yet the plasma membrane remained resistant to sPLA2. Phosphatidylserine was added
exogenously to the membrane, but no fatty acid release resulted. These two effects were not
sufficient (either on their own or in combination) to allow large amounts of hydrolysis as with
ionomycin-treatment. Again, Patman equilibration kinetics analyses detected biophysical
changes in ionomycin treatment that were absent in temperature experiments. Just as with TG
treatment, ionophore treatment caused a decrease in lipid anchoring to the center of the bilayer.
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Previously, no mechanism for this important physical change to the membrane had been
proposed. Here it was shown that the severing and disrupting of the actin cytoskeleton was
present in ionomycin-treated cells (susceptible) but not in cells incubated at high temperatures
(resistant). Furthermore, the onset of actin severing during TG apoptosis preceded susceptibility
to sPLA2. Future experiments utilizing actin-disrupting drugs will be performed to provide
further evidence that cytoskeletal alterations are responsible for membrane changes leading to
susceptibility to hydrolytic enzymes.
Many biophysical membrane studies focus on artificial bilayers, but the end goal is to
understand systems that are more physiologically relevant. This study was exciting in that it was
successful in examining changes at such a molecular level in a system as complex as a living
cell. It combined the classic use of fluorescent membrane probes with parallel data collected in
artificial membranes as well as computer simulations and models to gain more details than
previously possible. This is also the first attempt at suggesting mechanisms for the biophysical
alterations discussed. A novel function of the intact cytoskeleton is also proposed: to protect the
plasma membrane from hydrolytic damage.
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